vindesine has been researched along with Lung Neoplasms in 443 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 158 (35.67) | 18.7374 |
| 1990's | 209 (47.18) | 18.2507 |
| 2000's | 72 (16.25) | 29.6817 |
| 2010's | 4 (0.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, T; Tateishi, U; Terauchi, T; Torii, I | 1 |
| Huang, G; Lartigau, E; Shi, D; Shi, G; Zhang, J | 1 |
| Chen, P; Dai, CH; Li, J; Li, XQ; Shi, SB; Wu, JR; Yu, LC | 1 |
| Harita, S; Hiraki, A; Hiraki, S; Hotta, K; Kamei, H; Kanazawa, S; Kiura, K; Matsuo, K; Nogami, N; Segawa, Y; Shibayama, T; Sugimoto, K; Tabata, M; Takata, I; Takemoto, M; Takigawa, N; Tanimoto, M; Ueoka, H; Watanabe, Y; Yonei, T | 1 |
| Chiba, Y; Fukuoka, M; Hida, T; Imamura, F; Iwamoto, Y; Katakami, N; Kawahara, M; Kudo, S; Nakagawa, K; Nishimura, Y; Saka, H; Satouchi, M; Sawa, T; Semba, H; Seto, T; Takeda, K; Tsujino, K; Uejima, H; Yamamoto, N; Yokota, S | 1 |
| Gemba, K; Horita, N; Hotta, K; Kanazawa, S; Kiura, K; Matsuo, K; Moritaka, T; Nagata, T; Okimoto, N; Segawa, Y; Shinkai, T; Tabata, M; Takeda, H; Takemoto, M; Takigawa, N; Tamaoki, A; Tanimoto, M; Tokuda, Y; Ueoka, H; Watanabe, K | 1 |
| Borsellino, N; Caruso, M; Colucci, G; Durini, E; Galetta, D; Gebbia, N; Gebbia, V; Gridelli, C; Pezzella, G; Riccardi, F; Valdesi, M; Valenza, R | 1 |
| De Ruysscher, D; Lievens, Y; Nackaerts, K; Van den Brande, P; Vansteenkiste, J | 1 |
| Hayashi, E; Huang, CL; Kameyama, K; Liu, D; Okamoto, T; Yamamoto, Y; Yokomise, H | 1 |
| Jodkiewicz, Z; Radzikowska, E; Rowińska-Zakrzewska, E; Sakowicz, A; Szturmowicz, M; Słodkowska, J; Załeska, J; Załeska, M; Zych, J | 1 |
| Liu, SJ; Qiang, E; Wang, SP; Yiao, J | 1 |
| Mornex, F | 1 |
| Gong, LY; Jiang, CM; Pang, MR | 1 |
| Ichinose, Y; Kato, H; Koike, T; Mori, T; Nagai, K; Tada, H; Tsuchiya, R | 1 |
| Fukuyama, Y; Ichinose, Y; Yamaguchi, M | 1 |
| Vergnenègre, A | 1 |
| Bosquée, L; D'Odemont, JP; Dams, N; Delobbe, A; Deman, R; Deschepper, K; Dooms, C; Galdermans, D; Nackaerts, K; Siemons, L; Van den Brande, P; Van Kerckhoven, W; Vandebroek, J; Vandeurzen, K; Vansteenkiste, J | 1 |
| Langer, CJ | 2 |
| Clerici, M; Cognetti, F; Crinò, L; Fossati, R; Giaccone, G; Martelli, M; Scagliotti, GV; Silvano, G; Tonato, M; Torri, V | 1 |
| Eguchi, K; Kobayashi, K; Matsumoto, T; Morita, S; Ohashi, Y; Sakamoto, J; Shibuya, M; Yamaji, Y | 1 |
| Asamoto, H; Ishiguro, T; Kawahara, M; Maeda, H; Ogawara, M; Sawa, T; Yamamoto, S; Yokota, S; Yoshida, T | 1 |
| Ichinose, Y; Isobe, T; Katakami, N; Kawahara, M; Kubota, K; Kudo, S; Kunitoh, H; Matsui, K; Niitani, H; Nishiwaki, Y; Noda, K; Ohashi, Y; Segawa, Y; Shibuya, M; Sugiura, T; Watanabe, K; Yokota, S; Yokoyama, A; Yoneda, S | 1 |
| Arriagada, R; Bergman, B; Dunant, A; Le Chevalier, T; Pignon, JP; Vansteenkiste, J | 1 |
| Ichinose, Y; Kato, H; Koike, T; Nagai, K; Nishizawa, N; Tada, H; Tsuchiya, R | 1 |
| Berdel, WE; Braunheim, M; Heinecke, A; Hoffknecht, P; Klinke, F; Macha, HN; Riesenbeck, D; Schmidt, EW; Schumacher, A; Semik, M; Thomas, M; Wewers, D; Willich, N | 1 |
| Eigentler, TK; Garbe, C | 1 |
| Du, GZ; Gao, JF; Li, CS; Ou, WL; Wang, J; Yang, B; Zhang, BC; Zhang, XH; Zhu, YZ | 1 |
| Lu, B; Lu, MJ; Xu, JF; Zhang, J; Zheng, D; Zhou, CC | 1 |
| Anrys, B; De Leyn, P; Dooms, C; Lievens, Y; Lorent, N; Nackaerts, K; Van Raemdonck, D; Vansteenkiste, J; Verbeken, E | 1 |
| Blackstein, ME; Burkes, RL; Farooq, S; Ginsberg, RJ; Goldberg, ME; Jones, D; McGlaughlin, J; Patterson, GA; Pearson, FG; Shepherd, FA; Todd, T; Waters, PF | 1 |
| Berille, J; Derenne, JP; Gatineau, M; Jauffret, E; Khayat, D; Orcel, B; Rixe, O; Spano, JP; Vannetzel, JM | 1 |
| Girling, DJ; Hopwood, P; Stephens, RJ; Thatcher, N | 1 |
| Imaizumi, M | 1 |
| Andersen, PK; Dombernowsky, P; Nielsen, D; Osterlind, K; Ryberg, M; Skovsgaard, T | 1 |
| Ichinose, Y; Okamoto, T | 1 |
| Asamura, H; Kodama, T; Kunitoh, H; Matsuno, Y; Ohe, Y; Saijo, N; Sekine, I; Takei, H; Tamura, T; Tsuchiya, R; Yamamoto, N; Yamazaki, S | 1 |
| Athanassiades, P; Kostis, E; Lagoudis, M | 1 |
| Dooms, CA; Lievens, YN; Vansteenkiste, JF | 1 |
| Funakoshi, Y; Kadota, Y; Kawamura, S; Koma, M; Maeda, H; Matsubara, Y; Takeda, S | 1 |
| Azzoni, P; Cetto, GL; Genestreti, G; Manno, P; Micciolo, R; Molino, A; Pattaro, C; Santo, A; Sava, T; Terzi, A | 1 |
| Araki, O; Ishihama, H; Karube, Y; Kobayashi, S; Miyoshi, S; Nagai, S; Sawabata, N; Seki, N; Tamura, M; Umezu, H; Yoshii, N | 1 |
| Cucherat, M; Douillard, JY; Fossella, F; Georgoulias, V; Kubota, K; Kudoh, S; Laporte, S; Monnier, A; Pujol, JL; Rubio, JE | 1 |
| Drings, P; Gropp, C; Havemann, K; Konrad, RM; Liesenfeld, A; Mahnke, HG; Seifert, W; Thomas, C; Wellens, W; Westerhausen, M | 1 |
| Alberto, P; Cavalli, F; Joss, RA; Jungi, WF; Obrecht, JP; Sauter, C | 1 |
| Daugaard, G; Hansen, HH; Rørth, M | 1 |
| Arnold, E; König, HJ; Sander, U; Walter, M | 1 |
| Krischke, W; Niederle, N; Schmidt, CG; Schütte, J; Seeber, S | 1 |
| Chang, AY; Ramirez, G; Tormey, DC; Witte, RS | 1 |
| Braun, DW; Casper, ES; Chapman, RA; Golbey, R; Gralla, RJ; Heelan, RT; Howard, JE; Itri, LM; Kelsen, DP | 1 |
| Gunstream, SR; McMahon, LJ; Seidenfeld, JJ; Sobonya, RE | 1 |
| Eddleston, B; Johnson, RJ; Read, G; Wilkinson, PM | 1 |
| Eguchi, K; Ohkura, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Takahashi, K; Tominaga, K | 1 |
| Soukop, M | 1 |
| Allan, SG; Cornbleet, MA; Crompton, GK; Grant, IW; Gregor, A; Leonard, RC; Smyth, JF | 1 |
| Klastersky, J; Sculier, JP | 2 |
| Eguchi, K; Iwashita, K; Niitani, H; Saijo, N; Shimabukuro, Z; Shimizu, E; Shinkai, T; Tominaga, K | 1 |
| Charles, NC; Schafrank, M; Sierocki, JS; Wittes, RE | 1 |
| Carlin, DA; Grozea, PN; Miller, TP; Weick, JK | 1 |
| Evans, BD; Millar, JL; Shorthouse, AJ; Smith, IE | 1 |
| Conroy, JA; Kennedy, BJ; Peterson, BA; Vogelzang, NJ; Vosika, GJ | 1 |
| Aisner, J; Carney, DN; Fuks, JZ; Ihde, DC; Ostrow, SS; Van Echo, DA; Wiernik, PH | 1 |
| Brunner, KW; Goldhirsch, A; Joss, RA | 1 |
| Havemann, K | 1 |
| Aisner, J; Bachur, NR; Egorin, MJ; Fuks, JZ; Ostrow, S; Van Echo, DA; Wiernik, PH | 1 |
| Bitran, JD; Golomb, HM; Hoffman, PC | 1 |
| Cartei, G; Ferrazzi, E; Fiorentino, MV; Galligioni, E; Pappagallo, GL; Vinante, O; Zagonel, V | 1 |
| Eguchi, K; Saijo, N; Shibuya, M; Shimabukuro, Z; Shimizu, E; Shinkai, T; Tominaga, K | 1 |
| Bakowski, MT; Crouch, JC | 1 |
| Clark, RA; Hutcheon, AW; Palmer, JB; Pratt, MA | 1 |
| Niederle, N; Schmidt, CG; Schütte, J; Seeber, S | 1 |
| Broun, GO; Leavitt, J; Luedke, DW; Luedke, SL; Petruska, P; Schlueter, J | 1 |
| Blum, RH; Foreman, JD; Muggia, FM | 1 |
| Domenge, C; Richard, JM | 1 |
| Drings, P; Kleckow, M; Manke, HG; Stiefel, E | 1 |
| Miller, TP; Takasugi, BJ | 1 |
| Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R | 2 |
| Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Mermillod, B | 1 |
| Albain, KS; Bitran, JD; Blough, RR; DeMeester, TR; Golomb, HM; Hoffman, PC; Noble, S; Skosey, C | 1 |
| Bitran, JD; Ward, K | 1 |
| Ahmedzai, S; Banham, SW; Calman, KC; Dorward, AJ; Elliott, JA; Hole, D; Kaye, SB; Stack, BH; Stevenson, RD | 1 |
| Eguchi, K; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Tominaga, K | 1 |
| Honma, T; Min, KY; Nakagawa, H; Yoneda, S; Yoshida, S | 1 |
| Clark, GM; Sledge, GW; Von Hoff, DD | 1 |
| Baker, LH; Costanzi, JJ; Quagliana, JM; Stephens, RL | 1 |
| Braun, DW; Casper, ES; Dukeman, ME; Golbey, RB; Gralla, RJ; Kelsen, DP; Martini, N; Young, CW | 1 |
| Casper, E; Cheng, E; Golbey, R; Gralla, R; Kelsen, D; Kosloff, C; Stoopler, M | 1 |
| Dombernowsky, P; Hansen, HH; Hørbov, S; Osterlind, K; Rørth, M | 1 |
| Chiarion Sileni, V; Ferrazzi, E; Fiorentino, MV; Fosser, V; Paccagnella, A; Salvagno, L; Zagonel, V | 1 |
| Broun, GO; Leavitt, J; Luedke, DW; Luedke, SL; Petruska, P; Reed, G | 1 |
| Cobleigh, MA; Einhorn, LH; Furnas, BE; Williams, SD | 1 |
| Atassi, G; Dumont, P; Vandendris, M | 1 |
| Ford, CH; Johnson, JR; Newman, CE; Rowland, GF; Simmonds, RG; Woodhouse, CS | 1 |
| Golbey, RB; Gralla, RJ; Natale, RB; Wittes, RE; Young, CW | 1 |
| Ahlstedt, S; Holsti, LR; Holsti, P; Mattson, K; Saastamoinen, M; Salmo, M | 1 |
| Bernard, JP; Fournel, P; Jorda, M; Laennec, E; Piperno, D; Rebattu, P; Souquet, PJ; Trillet, V | 1 |
| Abad, A; Ariza, A; Barnadas, A; Carles, J; Fernandez-Vasalo, G; Pellicer, I; Rosell, R; Sanchez, JJ | 1 |
| Kozielski, J; Rauer, R; Spychałowicz, W; Ziora, D | 1 |
| Barduagni, M; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A | 1 |
| Boni, C; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A | 1 |
| Klinke, F; Micke, O; Rübe, C; von Eiff, M; Wagner, W; Willich, N | 1 |
| Bitran, JD; Gulati, SC | 1 |
| Hillner, BE; Le Chevalier, T; McSorley, PA; Neighbors, DM; Smith, TJ | 1 |
| Gohma, I; Inoue, T; Kobashi, Y; Kohri, Y; Matsumura, Y; Mino, M; Oida, K; Taguchi, Y; Takano, Y; Tomii, K | 1 |
| Cram, L; Gregor, A; Hansen, HH; Macbeth, FR; Paul, J | 1 |
| Balmes, P; Carles, P; Collus, MJ; Guerin, JC; Kleisbauer, JP; Perol, M; Poirier, R; Taytard, A; Thomas, P; Vergnenegre, A | 1 |
| Berchier, MC; Bureau, G; Dabouis, G; Klastersky, J; Libert, P; Ries, F; Schmerber, J; Sculier, JP; Thiriaux, J; Van Cutsem, O | 2 |
| Akira, M; Furuse, K; Kawahara, M; Kodama, N; Kubota, K; Kusunoki, Y; Nakajima, S; Negoro, S; Ogawara, M; Takada, M | 1 |
| Eguchi, K; Fukuda, M; Ohe, Y; Oshita, F; Saijo, N; Shinkai, T; Tamura, T; Yamamoto, N | 1 |
| Ando, M; Eguchi, K; Katsumata, N; Maeda, M; Ohe, Y; Oshita, F; Shinkai, T; Shiraishi, J; Tamura, T; Yamamoto, N | 1 |
| Plasswilm, L | 1 |
| Alberto, P; Bolla, M; Brambilla, E; Leyvraz, S; Mermillod, B; Mirimanoff, RO; Moro, D; Nagy-Mignotte, H; Wellmann, D | 1 |
| Kishiro, I; Mori, K; Suga, Y; Tominaga, K; Tsurui, M; Yokoyama, K | 1 |
| Fujii, M; Fukuoka, M; Furuse, K; Ikegami, H; Katakami, N; Nakai, Y; Nakajima, S; Negoro, S; Takada, Y; Yamori, S | 1 |
| Alberola, V; Cardenal, F; Carrato, A; Díaz-Rubio, E; González Larriba, JL; Gracia, JM; Lianes, P; Moyano, A; Muñoz Quintana, A; Panizo, A | 1 |
| Arias, F; Domínguez, MA; Illarramendi, JJ; López, R; Martínez, E; Tejedor, M; Valerdi, JJ | 1 |
| Bezwoda, WR; Vorobiof, DA | 1 |
| Coldman, A; Coppin, C; Murray, N; Pater, J; Rapp, E | 1 |
| Alberola, V; Besson, F; Chomy, P; Cigolari, S; Douillard, JY; Le Chevalier, T; Lianes, P; Monnier, A; Pujol, JL; Riviere, A | 1 |
| Furuse, K; Kawahara, M; Kodama, N | 1 |
| Fujita, F; Fujita, M; Sakamoto, Y | 2 |
| Aoshiba, K; Konno, K; Nagai, A; Ueno, H | 1 |
| Hojo, H; Kodama, T; Matsumoto, T; Nagai, K; Nishiwaki, Y; Nishiyama, H | 1 |
| Doi, O; Higashiyama, M; Kodama, K; Kuriyama, K; Yokouchi, H | 1 |
| Berchier, MC; Bureau, G; Dabouis, G; Libert, P; Michel, J; Paesmans, M; Ries, F; Sculier, JP; Van Cutsem, O; Vandermoten, G | 1 |
| Bains, MS; Gralla, RJ; Hilaris, B; Kris, MG; Martini, N; McCormack, PM; Pisters, KM | 1 |
| Beer, M; Fountzilas, G; Karantanas, A; Klouvas, G; Nicolaides, C; Pavlidis, NA | 1 |
| Arriagada, R; Douillard, JY; Lacombe-Terrier, MJ; Laplanche, A; Le Chevalier, T; Martin, M; Quoix, E; Ruffie, P; Tarayre, M | 2 |
| Alberola, V; Brisgand, D; Chomy, P; Cigolari, S; Douillard, JY; Le Chevalier, T; Lianes, P; Monnier, A; Pujol, JL; Riviere, A | 1 |
| Cerrina, J; Chapelier, AR; Dartevelle, PG; Ladurie, FL; Lenot, B; Macchiarini, P; Monnet, I; Parquin, F; Rebischung, JL; Vannetzel, JM | 1 |
| Arioka, H; Eguchi, K; Karato, A; Kunikane, H; Nishio, M; Ohe, Y; Oshita, F; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Eguchi, K; Kabe, J; Kudo, S; Mano, K; Morinari, H; Nakada, K; Noda, K; Saito, Y; Tanaka, T; Uzawa, T | 1 |
| Becker, H; Dannhäuser, J; Goerg, R; Hans, K; Hässler, R; Holle, R; Klaasen, HA; Pfab, R; von Bültzingslöwen, F; Wolf, M | 1 |
| Nakano, K; Saito, H; Satake, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Arcangeli, G; Marini, G; Marpicati, P; Meriggi, F; Milano, S; Simoncini, E; Zaniboni, A | 1 |
| Azli, N; Cvitkovic, E; de Cremoux, H; Monnet, I; Riggi, M; Ruffie, P; Saltiel, JC; Villalobos, W; Voisin, S | 1 |
| Iwata, M; Miyachi, T; Murate, T; Nomura, F; Ogasawara, T; Saito, H; Saka, H; Sakai, S; Shimokata, K; Yamamoto, M | 1 |
| Asada, M; Ashizawa, T; Gomi, K; Hirata, T; Kobayashi, E; Okabe, M | 1 |
| Bando, H; Doi, H; Kimura, K; Kobayashi, M; Nakayama, T; Ogura, T; Sasaki, H; Shimizu, E; Sone, S; Takishita, Y | 1 |
| Mori, K; Saitoh, Y; Tominaga, K | 1 |
| Cantwell, BM; Corris, PA; Harris, AL; Millward, MJ; Munro, NC; Robinson, A | 1 |
| Dimaiuta, M; Fossati, V; Gramegna, G; Mantellini, P; Mezzetti, M; Scanni, A; Tomirotti, M | 1 |
| Bains, MS; Burt, ME; Flehinger, BJ; Gralla, RJ; Heelan, R; Kris, MG; Martini, N; McCormack, PM; Pisters, KM; Rigas, JR | 1 |
| Kubo, S; Nishio, K; Nishio, M; Ohmori, T; Ohta, S; Saijo, N; Takahashi, T | 1 |
| Artal, A; Barón, JM; Berrocal, A; Feliu, J; García Girón, C; Garrido, P; González Barón, M; Ordóñez, A | 1 |
| Gralla, RJ; Heelan, RT; Kris, MG; Martini, N; Pisters, KM; Zaman, MB | 1 |
| Mori, K; Suga, Y; Takahashi, T; Tominaga, K | 1 |
| Balmes, P; Bonnaud, F; Carles, P; Guerin, JC; Kleisbauer, JP; Le Caer, H; Perol, M; Poirier, R; Taytard, A; Thomas, P | 1 |
| Miyazawa, N; Mori, T; Ohta, M; Sawamura, K; Shimoyama, M; Suemasu, K; Terashima, M; Tomita, M; Tsuchiya, R; Watanabe, Y | 1 |
| Kimura, H; Yamaguchi, Y | 2 |
| Hada, Y; Hiramoto, T; Ishida, H; Kohjima, N; Kumagai, K; Nakano, K | 1 |
| Araki, J; Fujino, S; Fukuda, M; Hara, K; Itoh, N; Kanda, T; Kinoshita, A; Nakano, M; Oka, M; Sakamoto, A; Soda, H; Watanabe, K | 1 |
| Hillner, BE; Smith, TJ | 1 |
| Hasegawa, S; Ishikawa, H; Satoh, H; Yano, H | 1 |
| Higashino, K; Igarashi, T; Ikegami, H; Kawase, T; Komuta, K; Nakamura, S; Nakano, T; Nishikawa, H; Tachibana, T; Yokota, S; Yoshida, M | 1 |
| Eguchi, K; Fakuda, M; Kasai, T; Kurata, T; Ohe, Y; Oshita, F; Saijo, N; Shinkai, T; Tamura, T; Yamamoto, N | 1 |
| Brancaccio, L; Carnicelli, P; Cioffi, R; Comella, P; De Cataldis, G; Ianniello, GP; Lombardi, A; Maiorino, A; Scarpati, MD; Tinessa, V | 1 |
| Hitomi, S; Teramatsu, T; Wada, H | 1 |
| Arriagada, R; Baldeyrou, P; Bretel, JJ; Cosset, BP; Grunenwald, D; Le Chevalier, T; Le Péchoux, C; Ruffié, P | 1 |
| Miyazawa, N; Yokoi, K | 1 |
| Fujita, A; Sekine, K; Sohda, T; Tagaki, S; Takabatake, H | 1 |
| Alberola, V; Berthaud, P; Besenval, M; Besson, F; Brisgand, D; Chevreau, C; Chomy, P; Cigolari, S; Douillard, JY; Gaspard, MH; Gottfried, M; Le Chevalier, T; Le Groumellec, A; Martinez, A; Monnier, A; Pujol, JL; Rivière, A; Ruffie, P; Tursz, T | 1 |
| Balmes, P; Carles, P; Grivaux, M; Guérin, JC; Kleisbauer, JP; Paillotin, D; Pérol, M; Pham, E; Poirier, R; Robinet, G; Thomas, P; Touron, D; Vergnenègre, A | 1 |
| Perol, M; Pham, E; Vergnenègre, A | 1 |
| Gatzemeier, U; Schneider, A; von Pawel, J | 1 |
| Berchier, MC; Bureau, G; Giner, V; Klastersky, J; Kroll, F; Küstner, U; Lecomte, J; Michel, J; Mommen, P; Paesmans, M; Sculier, JP; Sergysels, R; Van Cutsem, O | 1 |
| Fujita, H; Fujita, K; Fukuda, Y; Fukushima, M; Ishioka, T; Ito, H; Kishibe, S; Kogawa, R; Koie, H; Kudo, T; Machida, S; Maruyama, A; Sato, T; Takashima, K; Tsuge, T; Tsushima, T; Yagihashi, N | 1 |
| Ota, K | 1 |
| Bertrand, P; Bockaert, J; De Beukelaar, T; De Muynck, P; Deman, R; Mariën, S; Roex, L; Ulrichts, H; Vandebroek, J; Vansteenkiste, J | 1 |
| Adachi, S; Hasegawa, T; Ishii, N; Katakami, N; Nakai, H; Nakano, K; Takada, Y; Tamura, R; Tsubota, N; Umeda, B | 1 |
| Dalesio, O; Drings, P; Giaccone, G; Helle, P; Kirkpatrick, A; McVie, G; Planting, A | 1 |
| Dancey, J; Steward, WP | 1 |
| Di Fabio, D; Marini, G; Milano, S; Mombelloni, G; Ottoni, DB; Zaniboni, A; Zorzi, F | 1 |
| Fukuoka, M; Furuse, K; Katagami, N; Kawahara, M; Kinuwaki, E; Kuba, M; Kubota, K; Nakai, Y; Negoro, S; Niitani, H; Sakuma, A; Takada, Y; Yamori, S | 1 |
| Airoma, G; Bianco, AR; Cognetti, F; D'Aprile, M; De Placido, S; Gallo, C; Gebbia, V; Gridelli, C; Incoronato, P; Leonardi, V; Natali, M; Palazzolo, G; Palmeri, S; Pepe, R; Perrone, F; Rossi, A; Russo, A; Scinto, AF; Veltri, E | 1 |
| Akiyama, Y; Fujii, Y; Kondo, H; Shirono, R | 1 |
| Akira, M; Atagi, S; Furuse, K; Kamimori, T; Kawahara, M; Kodama, N; Kubota, K; Naka, N; Ogawara, M | 1 |
| Athanassiadis, A; Fountzilas, G; Klouvas, G; Kosmidis, P; Mylonakis, N; Nicolaides, C; Pavlidis, N; Samantas, E; Skarlos, D | 1 |
| Aramendía, JM; Aristu, J; Azinovic, I; Brugarolas, A; Herreros, J; Martínez-Monge, R; Rebollo, J; Viera, JC | 1 |
| Li, JH | 1 |
| Chimoto, M; Ikeda, Y; Ishihama, H; Kobayashi, S; Nagai, S; Shimada, K; Sugita, K; Umezu, H | 1 |
| Hara, N; Inutsuka, S; Kawasaki, M; Nakanishi, Y; Takayama, K; Tsuruta, N; Wakamatsu, K; Yatsunami, J | 1 |
| Buccheri, G; Ferrigno, D | 1 |
| Barriere, JR; Bonnaud, F; Clavier, J; Kleisbauer, JP; Paillotin, D; Pignon, T; Poirier, R; Pommier De Santi, P; Robinet, G; Taytard, A; Thomas, P; Vernenegre, A | 1 |
| Arriagada, R; Baldeyrou, P; Bretel, JJ; Grunenwald, D; Le Chevalier, T; Le Péchoux, C; Pellae-Cosset, B; Ruffié, P | 1 |
| Hitomi, S; Otake, Y; Tanaka, F; Wada, H | 1 |
| Junker, K; Rübe, C; Semik, M; Thomas, M; von Eiff, M | 1 |
| Fukuoka, M; Furuse, K; Kawahara, M; Kodama, N; Kubota, K; Kudoh, S; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ogawara, M; Takada, M; Takifuji, N | 1 |
| Masuda, N | 2 |
| Sun, Y; Wang, J; Zhang, H | 1 |
| Cvitkovic, E; Wasserman, E | 1 |
| Bandera, M; Beghe, B; Ceriani, L; Giovanella, L; Ortelli, M; Roncari, G | 1 |
| Akusawa, H; Horie, T; Kadota, A; Koya, Y; Masutani, M; Ohchi, Y; Takahashi, N; Tanigawa, S | 1 |
| Aoki, K; Ikeda, K; Ishida, K; Iwaya, T; Kimura, Y; Koeda, K; Ogasawara, S; Ohtsuka, K; Saito, K; Sato, N | 1 |
| Drings, P; Fischer, JR | 1 |
| Calista, D; Landi, C; Schianchi, S | 1 |
| Chrysanthopoulos, K; Dougenis, D; Ginopoulos, P; Gogos, CH; Kardamakis, D; Onyenadum, A; Solomou, E; Spyropoulos, K | 1 |
| Ashley, S; Hickish, T; Middleton, GW; Norton, A; O'Brien, ME; Priest, K; Smith, IE; Spencer, L | 1 |
| Ichiwata, T; Ishihara, Y; Kuramitsu, K; Ogata, T; Takizawa, T; Uchiyama, T; Yamamoto, M; Yoneda, S; Yoshida, K | 1 |
| Antilli, A; Ardizzoni, A; Baldini, E; Bandera, M; Barbera, S; Borghini, U; Cacciani, GC; Crippa, M; De Marinis, F; Ferrara, G; Fioretti, M; Galeasso, G; Lanfranco, C; Lepidini, G; Migliorino, MR; Noseda, MA; Pennucci, MC; Portalone, L; Raimondi, M; Rinaldi, M; Romano, F; Rosso, R; Salvati, F; Sunseri, G; Tibaldi, C | 1 |
| Hirota, S; Hishikawa, Y; Honda, K; Kono, K; Obayasi, K; Soejima, T; Takada, Y; Watanabe, H | 1 |
| Alberto, P; Bolla, M; Brambilla, C; Mermillod, B; Michel, G; Miralbell, R; Mirimanoff, RO; Moro, D | 1 |
| Aamdal, S; Andersson, R; Bjelkengren, G; Ingvar, C; Jungnelius, U; Karlsson, M; Malmström, P; Mattsson, J; Ringborg, U; Stierner, U; Westberg, R; Willman, K; Wist, E | 1 |
| De Ruysscher, D; Demedts, M; Spaas, P; Specenier, P; Van den Brande, P; Vansteenkiste, J | 1 |
| Ciccone, AM; Coloni, GF; De Giacomo, T; Rendina, EA; Ricci, C; Ruvolo, G; Venuta, F | 1 |
| Daenen, M; Demedts, M; Nackaerts, K; Van Bleyenbergh, P; Vandevelde, A; Vansteenkiste, J | 1 |
| Bisagni, G; Boni, C; Ceci, G; Crinò, L; De Lisi, V; Di Costanzo, F; Lasagni, L; Manenti, AL; Moretti, G; Rondini, E; Sassi, M; Savoldi, L; Zadro, A | 1 |
| Bergman, B; Dombernowsky, P; Hansen, HH; Krarup, M; Nielsen, AL; Sørensen, JB | 1 |
| Ayoub, J; Champagne, F; Contandriopoulos, AP; Kennedy, W; Reinharz, D; Tessier, G; Trabut, I | 1 |
| Bianco, A; Bilancia, D; Carpagnano, F; Cioffi, R; Comella, G; Comella, P; De Cataldis, G; De Lena, M; Di Rienzo, G; Frasci, G; Lorusso, V; Maiorino, L; Manzione, L; Natale, M; Nicolella, G; Pacilio, C; Panza, N | 1 |
| Hitomi, S; Miyahara, R; Tanaka, F; Wada, H | 1 |
| Coosemans, W; De Leyn, P; Deneffe, G; Lerut, T; Van Raemdonck, D; Vansteenkiste, J | 1 |
| Fukuda, M; Hayakawa, A; Itoh, N; Kohno, S; Mori, H; Oka, M; Sakamoto, T | 1 |
| Endo, K; Ichimura, H; Inoue, S | 1 |
| Beinert, T; Binder, D; Fleischhacker, M; Mergenthaler, HG; Oehm, C; Possinger, K; Priem, F; Schweigert, M; Sezer, O; Siebert, G; Stuschke, M; Werner, TG; Ziemer, S | 1 |
| Bains, M; Ginsberg, RJ; Grant, SC; Heelan, RT; Kris, MG; Martini, N; Miller, VA; Ng, KK; Pisters, KM; Rosenzweig, KE; Rusch, V | 1 |
| Kourakata, H; Miyamura, H; Saito, H; Sato, K; Sato, Y; Sugawara, M; Tanabe, Y; Togashi, K | 1 |
| Bréchot, JM; Chastang, C; L'Her, P; Lebas, FX; Lebeau, B; Leclerc, P; Meekel, P; Paillotin, D; Urban, T; Vincent, J | 1 |
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Katagami, N; Kawahara, M; Kudoh, S; Nishikawa, H; Takada, Y | 1 |
| Kurano, R; Ono, K; Semba, H; Seto, M; Seto, T | 1 |
| Haneda, H; Hayashi, T; Koizumi, M | 1 |
| Kageyama, Y; Urabe, N; Watanabe, K | 1 |
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Ikegami, H; Kubota, K; Kurita, Y; Saijo, N; Tamura, T | 1 |
| Eguchi, K; Fujiwara, K; Ida, M; Kishino, D; Segawa, Y; Takigawa, N | 1 |
| Fujimoto, K; Hayabuchi, N; Hayashi, A; Horiuchi, M; Mitsuoka, M; Oizumi, K; Rikimaru, T; Shirouzu, K; Takamori, S; Tayama, K | 1 |
| Paridaens, R; Vanhees, SL; Vansteenkiste, JF | 1 |
| Andrieu, JM; Coscas, Y; Dabouis, G; Jaillon-Abraham, C; Tourani, JM | 1 |
| Eguchi, K; Harada, M; Kiura, K; Miyamoto, H; Segawa, Y; Shibayama, T; Tabata, M; Takata, I; Takigawa, N; Ueoka, H | 1 |
| Hebisawa, A; Mikami, A; Sagara, Y; Tamura, A | 1 |
| Aoki, S; Fukuno, Y; Hayashi, SI; Kawashima, M; Kikuchi, Y; Yatsunami, J | 1 |
| Hirai, H; Kanda, A; Sasaki, H; Suzuki, T; Yanai, M | 1 |
| Aoki, H; Fukai, S; Hashimoto, K; Hayashihara, K; Ishida, T; Kuwahara, K; Minegishi, Y; Nemoto, E; Okano, T; Saito, T; Watanabe, K; Watanabe, S; Yanai, N | 1 |
| Budach, W; Dierkesmann, R; Eulenbruch, HP; Friedel, G; Hruska, D; Hürtgen, M; Kyriss, T; Toomes, H; Wolf, M | 1 |
| Aberola, V; Brisgand, D; Cigolari, S; Douillard, JY; Le Chevalier, T; Pujol, JL; Ruffie, P; Soria, JC | 1 |
| Doddoli, C; Fuentes, P; Giudicelli, R; Papazian, L; Reynaud-Gaubert, M; Thomas, P | 1 |
| Abiko, M; Ikeda, E; Saga, K; Sato, T; Takahashi, N | 1 |
| Kanzawa, F; Koh, Y; Nakamura, T; Nishio, K; Saijo, N; Tamura, T | 1 |
| Sone, S; Yano, S | 1 |
| Babović, N; Elezar, E; Gavrilović, D; Jelić, S; Kovacević, S; Kovcin, V; Mitrović, L; Radosavljević, D; Radulović, S; Tomasević, Z | 1 |
| Fujitaka, K; Isobe, T; Kagawa, K; Kohno, N; Miyazaki, M; Oguri, T; Yamasaki, M | 1 |
| Etoh, T; Fukuda, H; Fuwa, N; Hirai, K; Ishizuka, N; Kitamoto, Y; Kobayashi, H; Mori, K; Nakata, K; Ohe, Y; Saijo, N; Saito, A; Saka, H; Sawa, T; Sugiura, T; Tsuchiya, S | 1 |
| Dams, NL; Devogelaere, RC; Humblet, YP; Marien, SA; Nackaerts, KL; Valcke, YJ; Vandebroek, JE; Vansteenkiste, JF; Verresen, DA; Weynants, P | 1 |
| Berchier, MC; Berghmans, T; Florin, MC; Giner, V; Klastersky, J; Koumakis, G; Lafitte, JJ; Lecomte, J; Michel, J; Mommen, P; Ninane, V; Paesmans, M; Sculier, JP; Thiriaux, J; Van Cutsem, O | 1 |
| Liao, M; Lin, Z; Lu, S | 1 |
| Feng, F; Sun, Y; Zhang, X | 1 |
| Hayakawa, K; Ishizuka, N; Mori, K; Nishiwaki, Y; Ogino, T; Saijo, N; Saito, M; Sekine, I; Tsuchiya, S; Tsukiyama, I; Yokoyama, A; Yoshimura, K | 1 |
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Ikegami, H; Kishimoto, S; Kunikane, H; Saijo, N; Watanabe, K | 1 |
| Brisgand, D; Le Chevalier, T; Soria, JC | 1 |
| Fujii, T; Furue, H; Ikeda, M; Rikimaru, T; Taguchi, T; Tsukagoshi, S | 1 |
| Akira, M; Atagi, S; Hosoe, S; Kawaguchi, T; Kawahara, M; Mitsuoka, S; Naka, N; Ogawara, M; Okishio, K; Sunami, T | 1 |
| Hisada, T; Ito, T; Masuda, S; Mochida, A; Morinari, H; Nakahara, K; Nishi, K; Saito, K; Sasaki, S; Tahara, M; Yakumaru, K | 1 |
| Harada, M; Hiraki, S; Kiura, K; Kodani, T; Moritaka, T; Segawa, Y; Tabata, M; Takigawa, N; Tanimoto, M; Ueoka, H | 1 |
| Hosomi, Y; Shibuya, M | 1 |
| Miyazawa, N; Mori, K; Saito, Y; Tominaga, K; Yokoi, K | 4 |
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Hasegawa, K; Kuriyama, T; Motomiya, M; Niitani, H; Ota, K; Takada, M; Tominaga, K | 1 |
| Hirabayashi, M; Kawakami, K; Kuno, K; Mishima, M; Nakagawa, M; Tanaka, Y; Yoshida, H | 1 |
| Akita, H; Fujikane, T; Kawakami, Y; Miyamoto, H; Nakabayashi, T; Ohsaki, Y; Onodera, S; Sakai, E; Shimizu, T; Yasuda, S | 1 |
| Chapelier, A; Dartevelle, P; Rebischung, JL; Sauvaget, J; Vannetzel, JM | 1 |
| Sculier, JP | 1 |
| Blackstein, ME; Burkes, RL; Cooper, JD; Ginsberg, RJ; Goldberg, ME; Patterson, GA; Pearson, FG; Shepherd, FA; Todd, T; Waters, PF | 1 |
| Fukuoka, M; Kudoh, S; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Takada, M; Takifuji, N | 1 |
| Eguchi, K; Iemura, K; Kojima, A; Miya, T; Ohe, Y; Okamoto, H; Oshita, F; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Asamoto, H; Fukuoka, M; Furuse, K; Kimura, I; Niitani, H; Sakuma, A; Yamaguchi, Y | 1 |
| Airoma, G; Bianco, AR; Gridelli, C; Incoronato, P; Palazzolo, G; Pepe, R; Rossi, A | 1 |
| Algeri, R; Pepi, F; Schiaroli, G; Trusso, M; Tucci, E | 1 |
| Mori, K; Saito, Y; Tominaga, K | 1 |
| Arriagada, R; Baldeyrou, P; de Cremoux, H; Le Chevalier, T; Martin, M; Nasr, E; Pellae-Cosset, B; Ruffie, P; Tarayre, M | 1 |
| Karato, A; Miya, T; Saijo, N; Sasaki, Y | 1 |
| Lee, YK; Shin, DM | 1 |
| Gianoutsos, P; Grygiel, J; Lee, JH; McCaughan, BC; McNeil, E; Raghavan, D; Stockler, M | 1 |
| Balli, M; Bonciarelli, G; Jirillo, A; Lonardi, F; Pavanato, G | 1 |
| Avril, MF; Bertrand, P; Bizzari, JP; Cour, V; Gerard, B; Khayat, D | 1 |
| Gomi, K; Kobayashi, K; Niitani, H; Nomura, K; Ohno, H; Okabe, M | 1 |
| Arriagada, R; de Cremoux, H; Douillard, JY; Laplanche, A; Le Chevalier, T; Pignon, JP; Quoix, E; Ruffie, P; Tarayre, M | 1 |
| Eguchi, K; Kojima, A; Ohe, Y; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Blijham, GH; Bron, H; Hupperets, PS; Schouten, L; ten Velde, GP | 1 |
| Ash, CM; Geddes, D; Goldman, J; Harper, PG; Souhami, RL; Spiro, SG; Tobias, JS; Twelves, CJ | 1 |
| Kajita, M; Niimi, T; Saito, H | 1 |
| Fukuoka, M; Furuse, K; Kawahara, M; Kudoh, S; Masuda, N; Matsui, K; Negoro, S; Ogawara, M; Takada, M; Takifuji, N | 1 |
| Hara, N; Ohta, M | 1 |
| Furuse, K; Kawahara, M; Kodama, N; Kubota, K; Kusunoki, Y; Matui, K; Negoro, S; Takada, M; Takifuji, N; Yamamoto, M | 1 |
| Boutin, C; Charbonneau, J; Dietemann, A; Ducolone, A; Meurice, JC; Orlando, JP; Pauli, G; Quoix, E; Roegel, E | 1 |
| Hooi, LM; Iredale, JP; Kerr, KM; Sudlow, MF; Wathen, CG | 1 |
| Airoma, G; Garufi, C; Gebbia, V; Gentile, M; Gridelli, C; Iacobelli, S; Palmeri, S; Palmieri, G; Pepe, R; Russo, A | 1 |
| Gatzemeier, U; Heckmayr, M; Hossfeld, DK; Kaukel, E; Koschel, G; Neuhauss, R | 2 |
| Cvitkovic, E; de Cremoux, H; Huet, J; Martin, M; Monnet, I; Riggi, M; Ruffie, P; Saltiel, JC; Vergne, L; Voisin, S | 1 |
| Fujii, M; Hiraki, S; Kawahara, S; Kiura, K; Kozuka, A; Machida, K; Moritaka, T; Ohnoshi, T; Ueda, N; Ueoka, H | 1 |
| Bell, D; Byrne, M; Kerestes, ZL; Levi, J; Page, J; Williams, CJ; Woods, RL | 1 |
| Kamei, H; Kimura, I; Kodani, T; Ohnoshi, T; Ueoka, H | 1 |
| Aso, H; Hara, N; Ichinose, Y; Kuda, T; Motohiro, A; Ohta, M | 1 |
| Hayashi, S; Ogata, K; Ogino, H; Yagawa, K | 1 |
| Harada, Y; Horiguchi, T; Kimura, T; Nogimura, H; Sugimura, H; Suzuki, K; Tomii, M; Wada, H | 1 |
| Brambs, HJ; Drings, P; Kauffmann, G; Rieber, A; Wannenmacher, M | 1 |
| Fujisawa, T; Kikuchi, N; Miyamoto, T; Mizutani, F; Nagao, K; Nakano, K; Satoh, K; Takizawa, H; Yamagishi, F; Yamaguchi, T | 1 |
| Akiyama, J; Aoki, H; Chida, K; Genma, H; Honda, K; Okano, A; Okano, H; Sato, A; Taniguchi, M; Watanabe, T | 1 |
| Cavalli, F; Gatzemeier, U; Häussinger, K; Kaukel, E; Koschel, G; Martinelli, G; Neuhauss, R; von Pawel, J | 1 |
| Eguchi, K; Kojima, A; Miya, T; Ohe, Y; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Fujita, H; Ishimoto, K; Kiyokawa, N; Kyo, K; Mizuno, T; Takada, K; Yabuta, K | 1 |
| Ito, K; Kuramitsu, T; Matsumoto, T; Nakaki, H; Nakamura, H; Nishikawa, H; Suda, H; Suga, K; Tanaka, N; Uchisako, H | 1 |
| Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A | 1 |
| Bureau, G; Dabouis, G; Klastersky, J; Lecomte, J; Libert, P; Michel, J; Ravez, P; Sculier, JP; Thiriaux, J; Vandermoten, G | 1 |
| Fukuchi, Y; Ishida, K; Jo, C; Matsuse, T; Nagase, T; Orimo, H; Teramoto, S; Yamaoka, M | 1 |
| Fujii, T; Fujita, Y; Fukabori, T; Goto, T; Hiramori, N; Iwasaki, Y; Kida, T; Nakagawa, M; Nakamura, T | 1 |
| Bach, F; Dombernowsky, P; Hansen, HH; Sørensen, JB; Vibe-Petersen, J | 1 |
| Stathopoulos, GP | 1 |
| Andrieu, JM; Balzon, JC; Caubarrere, I; Darse, J; Delaisement, C; Geraads, A; Lebas, FX; Timsit, JF; Tourani, JM | 1 |
| Abad-Esteve, A; Barnadas, A; Carles, J; Culubret, M; Fernandez, C; Moreno, I; Ribelles, N; Rosell, R | 1 |
| Alvarez, LA; Bianco, A; Cuevas, MA; Leone, BA; Machiavelli, M; Perez, JE; Rabinovich, MG; Rodriguez, R; Romero, A; Vallejo, CT | 1 |
| Fukuoka, M; Kubota, K; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N | 1 |
| Koga, K; Minoda, S; Murai, N; Nishikawa, K | 1 |
| Bartolucci, AA; Birch, R; Einhorn, L; Greco, FA; Luedke, DW; Omura, GA; Sarma, PR | 1 |
| Fujii, M; Genba, K; Matsutomo, S; Segawa, Y | 1 |
| Fukutani, H; Hirano, A; Horikoshi, N; Inoue, K; Itami, S; Mizunuma, N; Mukaiyama, T; Nakagawa, K; Ogawa, M; Tabata, M | 1 |
| Alberto, P; Bürki, K; Cavalli, F; Dalquen, P; Joss, RA; Leyvraz, S; Ludwig, C; Schatzmann, E; Siegenthaler, P; Stahel, R | 1 |
| Allard, P; Benichou, J; Brechot, JM; Chastang, C; Coetmeur, D; Dautzenberg, B; Lebeau, B; Postal, MJ | 1 |
| Koga, K; Minoda, S | 1 |
| Bartolucci, A; Birch, R; Einhorn, LH; Greco, FA; Johnson, DH; Omura, G; Perez, CA | 1 |
| Fukuoka, M; Furuse, K; Kawahara, M; Masuda, N; Matsui, K; Negoro, S; Takada, M; Takifuji, N | 1 |
| Hara, N; Ichinose, Y; Ohta, M | 1 |
| Häussinger, K; Jungbluth, H; Krieger, H; Laumen, R; Otto, M; von Pawel, J | 1 |
| Ammon, J; Andreopoulos, D; Karstens, JH | 1 |
| Goodwin, PJ; Jaakkimainen, L; Murray, N; Pater, J; Rapp, E; Warde, P | 1 |
| Adachi, S; Hayashi, Y; Ito, G; Kato, M; Matsuura, T; Takeuchi, T; Yamada, Y; Yamamoto, K | 1 |
| Curran, WJ | 1 |
| Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Suzuki, A | 1 |
| Lacroix, H; Sculier, JP | 1 |
| Andrieu, JM; Balzon, JC; Boita, F; Caubarrere, I; Darse, J; Lafitte, JJ; Lebas, FX; Penaud, D; Tourani, JM | 1 |
| Fujisawa, T; Odaka, E; Shiba, M; Suzuki, M; Urabe, N; Yamaguchi, Y | 1 |
| Asakawa, M; Fukuoka, M; Furuse, K; Nakai, H; Niitani, H; Nishiwaki, Y; Ogawa, N; Ota, M; Sakai, S | 1 |
| Fujita, J; Saijo, N | 1 |
| De Vries, EG; Koops, HS; Mulder, NH; Sleijfer, DT; Smit, JM; Willemse, PH | 1 |
| Aaronson, NK; Bakker, W; Bins, MC; Hermans, J; van Breukelen, FJ; van Oosterom, AT | 1 |
| Dombrowski, H; Drings, P; Hans, K; Harms, V; Havemann, K; Holle, R; Victor, N; Wolf, M | 1 |
| Inoue, F; Mimura, H; Miyake, M; Mori, T; Orita, K; Takeda, I; Tanaka, N | 1 |
| Fujiwara, K; Jyojya, I; Mitsuhata, N; Miyake, M; Ono, T; Sato, T | 1 |
| Ishii, J; Kawahara, S; Kiura, K; Moritaka, T; Nishii, K; Numata, T; Ohnoshi, T; Ueoka, H; Yamashita, H; Yonei, T | 1 |
| Hayashibara, K; Hirosawa, A; Niitani, H; Tsuboi, E | 1 |
| Drings, P | 1 |
| Bitran, JD; Ferguson, MK; Golomb, HM; Hoffman, PC; Vokes, EE; Weichselbaum, RR | 1 |
| Fiebig, HH; Hinkelbein, W; Wallbrecher, E; Wannenmacher, M | 1 |
| Hayashi, H; Hotta, T; Kanatsuna, T; Kondoh, M; Nakai, M; Nakano, K; Onodera, H; Sawada, M; Setoguchi, J; Sigeta, M | 1 |
| Fukuhara, H; Oomura, M; Sasaki, H | 1 |
| Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH | 1 |
| Holsti, LR; Holsti, P; Mattson, K; Niitamo-Korhonen, S; Pyrhönen, S | 1 |
| Isawa, T; Motomiya, M; Ono, R; Tamahashi, N | 1 |
| Dohi, Y; Houya, I; Kaneko, K; Kimura, I; Kiuchi, H; Kuramitsu, K; Nagata, M; Sakamoto, Y; Yamamoto, K | 1 |
| Aoyama, A; Baba, M; Hirata, S; Iizuka, K; Koizumi, K; Niitani, H; Ohtsuka, M; Sakai, S; Shibuya, M; Shohji, T | 1 |
| Eguchi, K; Fujiwara, Y; Kojima, A; Minato, K; Nakagawa, K; Nakajima, T; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Ando, N; Ide, H; Ishida, K; Kakegawa, T; Lizuka, T; Mori, S; Nashimoto, A; Sasaki, K; Takagi, I; Watanabe, H | 1 |
| Fukuchi, Y; Homma, S; Marumo, K; Matsuse, T; Nagase, T; Orimo, H; Suruda, T; Yamaoka, M; Yoshikawa, M | 1 |
| Bruguerolle, B; Cano, JP; Doalto, L; Focan, C; Hecquet, B; Levi, F; Mazy, V; Rahmani, R | 1 |
| Ford, CH; Richardson, VJ; Tsaltas, G | 1 |
| Badsberg, JH; Hansen, HH; Sørensen, JB | 1 |
| Alevizakos, N; Athanassiou, A; Bafaloukos, D; Barbounis, V; Dimitriadis, M; Pectasides, D; Varthalitis, J; Yianniotis, H | 1 |
| Hayashi, M; Itoh, H; Ooka, T; Shima, I; Watanabe, A | 1 |
| Fujii, M; Kimura, M; Kiura, K; Okabe, K; Toki, H | 1 |
| Holsti, LR; Holsti, P; Mattson, K; Niiranen, A; Salmo, M | 1 |
| Egawa, T; Hiraki, S; Ishii, J; Kawahara, S; Ohnoshi, T; Tamai, M; Tamura, T; Ueoka, H; Yamashita, H; Yonei, T | 1 |
| Barnett, MJ; Cheek, SP; Gregory, W; Harvey, VJ; Slevin, ML; Thompson, JP; Wrigley, PF | 1 |
| Bains, MS; Burt, ME; Gralla, RJ; Kaiser, LR; Kris, MG; Martini, N; McCormack, PM; Zaman, MB | 1 |
| Engelhardt, R | 1 |
| Weitberg, AB | 1 |
| Becker, H; Gropp, C; Hans, K; Havemann, K; Klasen, H; Maasberg, M; Schroeder, M; Stalleicken, D; von Bültzingslöwen, F; Wolf, M | 1 |
| Levi, J; Page, J; Williams, CJ; Woods, R | 1 |
| Becker, H; Bülzebruck, H; Djawid, N; Drings, P; Ruchalla, E; Stiefel, P; Tessen, HW | 1 |
| Gatzemeier, U; Heilmann, HP; Hossfeld, DK; Kaukel, E; Koschel, G; Zschaber, R | 1 |
| Devriendt, J; Klastersky, J; Michel, J; Mommen, P; Nguyen, H; Renaud, A; Sculier, JP; Van Houtte, P; Vandermoten, G | 1 |
| Arriagada, R; Baldeyrou, P; Le Chevalier, T; Ruffié, P; Thomas, F | 1 |
| Hasegawa, S; Kameyama, M; Naitoh, T; Ohtsuka, M; Satoh, H; Satoh, T; Suyama, T; Takahashi, N; Yano, H; Yoshizawa, Y | 1 |
| Carr, DT; Chiuten, DF; Dhingra, HM; Farha, P; Murphy, WK; Spitzer, G; Umsawasdi, T; Valdivieso, M | 1 |
| Burke, MT; Casper, ES; Cibas, IR; Fiore, JJ; Gralla, RJ; Heelan, RT; Kelsen, DP; Kris, MG | 1 |
| Drings, P; Manke, HG | 1 |
| Tanneberger, S | 1 |
| Eguchi, K; Fujita, J; Futami, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Tominaga, K | 1 |
| Eguchi, K; Fujita, J; Futami, H; Ishihara, J; Saijo, N; Sakurai, M; Sasaki, Y; Shinkai, T; Takahashi, H; Tominaga, K | 1 |
| Berchet, JL; Cervantes, P; Feintrenie, X; Lamaze, R; Lamy, P; Vespignani, H | 1 |
| Birch, R; Hake, J; Logan, T; Luedke, DW; Luedke, SL; Martelo, O; Quesenberry, P; Schlueter, J | 1 |
| Fukuda, T; Homma, T; Kikuchi, K; Masuda, H; Matsuoka, T; Noguchi, Y; Ogata, T; Sugiyama, K; Yoneda, S; Yoshida, S | 1 |
| Bodey, GP; Carr, DT; Chiuten, DF; Dhingra, HM; Murphy, WK; Spitzer, G; Umsawasdi, T; Valdivieso, M | 1 |
| Fukuda, Y; Homma, T; Nakata, M; Noguchi, Y; Sakura, M; Yoneda, S; Yoshida, S | 1 |
| Eguchi, K; Keicho, N; Miyaoka, H; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Shinkai, T; Suga, J; Tominaga, K | 1 |
| Brandes, A; Chiarion Sileni, V; De Besi, P; Fornasiero, A; Fosser, VP; Paccagnella, A; Pappagallo, GL; Salvagno, L; Simioni, G; Vinante, O | 1 |
| Davidson, KG; Faichney, A; Hamilton, PS; Harvey, K; Kerr, H; Moyes, P; Simmonds, AP | 1 |
| Bonomi, PD; Ettinger, D; Mason, B; Pazdur, R; Stolbach, L | 1 |
| Morgan, DA | 1 |
| Höfeler, H; Höffken, K; Kath, R; Müller, M; Niederle, N; Schmidt, CG; Schoetensack, B; Wandl, U | 1 |
| Drings, P; Gropp, C; Hans, K; Havemann, K; Heim, M; Holle, R; Manke, HG; Schroeder, M; Victor, N; Wolf, M | 1 |
| Drings, P; Gropp, C; Hans, K; Havemann, K; Heim, M; Holle, R; Klapsing, J; Manke, HG; Schroeder, M; Viktor, N | 1 |
| Hain, E; Kaukel, E; Koschel, G | 1 |
| Hansen, HH; Osterlind, K; Sørensen, JB | 1 |
| De Vries, EG; Meijer, C; Mulder, NH; Postmus, PE | 1 |
| Inoue, I; Kawahito, K; Kimura, K; Nakahira, S; Nakamura, Y; Shimizu, E; Sone, S; Tani, K; Yamasaki, K; Yamashita, T | 1 |
| Aabo, K; Bork, E; Bødker, B; Dombernowsky, P; Hansen, HH; Hansen, M; Malmberg, R; Sørensen, JB | 1 |
| Chen, KM; Hamburger, AW; Hoshi, A; Ishihara, J; Lee, YC; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Takahashi, H | 1 |
| Drasga, R; Einhorn, LH; Fisher, W; Gabrys, T; Loehrer, PJ; Meyers, S; Nattan, SR; Songer, J; Williams, SD; Woodburn, R | 1 |
| Fujieda, K; Ibe, Y; Ito, T; Morinari, H; Naito, S; Okubo, S | 1 |
| Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N; Tsubura, E | 1 |
| Fujikane, T; Shimizu, T | 1 |
| Hasegawa, M; Miyashita, K; Muto, T; Sasaki, K; Suzuki, S; Suzuki, T; Tanaka, O | 1 |
| Atsumi, M; Fuse, Y; Kataoka, K; Takeda, S; Takino, T; Taniwaki, M; Tsuji, T | 1 |
| Kawamura, M; Komatsu, H; Satou, K; Yoneda, R | 1 |
| Creech, RH; Ettinger, DS; Finkelstein, DM; Joss, RA; Mason, BA; Ruckdeschel, JC; Vogl, S | 1 |
| Burke, MT; Cibas, IR; Fiore, JJ; Gralla, RJ; Heelan, RT; Kelsen, DP; Kris, MG; O'Connell, JP; Wertheim, MS | 1 |
| Ahmann, FR; Miller, TP; Rodney, SR; Vance, RB | 1 |
| Bartlett, SE; Casson, AG; Ford, CH; Gallant, ME; Marsden, CH | 2 |
| Akiba, T; Eguchi, K; Fujiwara, Y; Miyamoto, K; Saijo, N; Sakurai, M; Sasaki, Y; Shinkai, T; Tamura, T; Uei, Y | 1 |
| Andrieu, JM; Brzecka, A; Marin, I | 1 |
| Bott, SJ; Prince-Fiocco, MA; Stewart, FM | 1 |
| Becquart, D; Dalesio, O; Dumont, JP; Klastersky, J; Libert, P; Mommen, P; Ravez, P; Rocmans, P; Sculier, JP; Vandermoten, G | 1 |
| Elliott, JA | 1 |
| Fujii, M; Kiura, K | 1 |
| Clark, RA; Hutcheon, A; Main, J | 1 |
| Davidson, KG; Faichney, A; Moyes, P; Nicol, A; Simmonds, AP | 1 |
| de Vries, EG; Mulder, NH; Postmus, PE; Schipper, DL | 1 |
| Nakada, T; Suda, H | 1 |
| Bagin, R; Burke, MT; Casper, ES; Cibas, IR; Gralla, RJ; Groshen, S; Heelan, RT; Kalman, LA; Kelsen, DP; Kris, MG | 1 |
| Daughaday, C; Harrison, B; Luedke, D; Luedke, S; Martello, O; McLaughlin, TT; Reed, G | 1 |
| Eguchi, K; Fujita, J; Futami, H; Kimata, M; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Takahashi, K; Tominaga, K | 1 |
| Albain, K; Bitran, JD; Evans, R; Golomb, HM; Hoffman, PC; Little, AG; Purl, S; Skosey, C | 1 |
| Birch, R; Enas, G; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Porter, LL; Wolff, SN | 1 |
| Klastersky, J | 1 |
| Aisner, J; Fuks, JZ; Hornedo, J; Patel, H; Van Echo, DA | 1 |
| Arriagada, R; Baldeyrou, P; Duroux, P; Le Chevalier, T; Martin, M; Rouesse, J; Ruffié, P; Tarayre, M | 1 |
| Schalhorn, A | 1 |
| Arriagada, R; Baldeyrou, P; Duroux, P; Jacquotte, A; Le Chevalier, T; Martin, M; Rouesse, J; Sancho-Garnier, H | 1 |
| Brune, J; Cordier, JF; Loire, R; Perinetti, M; Vergnon, JM; Vincent, M | 1 |
| Klastersky, J; Mommen, P; Sculier, JP | 1 |
| Ishihara, J; Kanzawa, F; Matsushima, Y; Miyazawa, N; Saijo, N; Sasaki, Y; Shimizu, E | 1 |
30 review(s) available for vindesine and Lung Neoplasms
| Article | Year |
|---|---|
[Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Pneumonectomy; Radiotherapy, Adjuvant; Vindesine | 2003 |
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Gemcitabine; Humans; Karnofsky Performance Status; Lung Neoplasms; Pain; Quality of Life; Time Factors; Treatment Outcome; Vindesine | 2003 |
The global role of irinotecan in the treatment of lung cancer: 2003 update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Irinotecan; Japan; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Staging; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; United States; Vindesine | 2003 |
[Therapy of malignant melanoma at the stage of distant metastasis].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Disease Progression; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Skin Neoplasms; Temozolomide; Time Factors; Tomography, X-Ray Computed; Vindesine | 2004 |
[Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Lung Neoplasms; Meta-Analysis as Topic; Mitomycin; Paclitaxel; Pneumonectomy; Postoperative Care; Randomized Controlled Trials as Topic; Tegafur; Uracil; Vinblastine; Vindesine; Vinorelbine | 2005 |
Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Taxoids; Vinblastine; Vindesine; Vinorelbine | 2007 |
Management of non-small-cell cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Prognosis; Vinblastine; Vincristine; Vindesine | 1984 |
Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Prognosis; Vinblastine; Vindesine | 1983 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Mitoguazone; Vinblastine; Vindesine | 1984 |
Chemotherapy of advanced non-small cell lung cancer. A review.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Lung Neoplasms; Vinblastine; Vindesine | 1984 |
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine | 1984 |
[Combination of cisplatin-mitomycin-vindesine for inoperable, non-small-cell bronchial cancers. French study group in pneumo-cancerology].
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Heart Diseases; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Staging; Palliative Care; Peripheral Nervous System Diseases; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Vindesine; Weight Loss | 1993 |
[Recent changes in the management of advanced non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Vindesine | 1994 |
[Nedaplatin].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Remission Induction; Urogenital Neoplasms; Vindesine | 1996 |
The role of vindesine in oncology--recommendations after 10 years' experience.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials as Topic; Humans; Leukemia; Lung Neoplasms; Lymphoma; Melanoma; Vindesine | 1995 |
[Adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Humans; Lung Neoplasms; Randomized Controlled Trials as Topic; Tegafur; Uracil; Vindesine | 1997 |
[Combination chemotherapy in the treatment of inoperable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Meta-Analysis as Topic; Mitomycin; Paclitaxel; Survival Rate; Vinblastine; Vindesine; Vinorelbine | 1997 |
Role of vindesine as neoadjuvant chemotherapy for non-small cell lung and head and neck cancers.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical Trials as Topic; Head and Neck Neoplasms; Humans; Lung Neoplasms; Vindesine | 1997 |
[Treatment of patients with recurrent esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Prognosis; Survival Rate; Vindesine | 1998 |
Role of vindesine in induction chemotherapy in locally-advanced non-small-cell lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical Trials as Topic; Humans; Lung Neoplasms; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Vindesine | 1998 |
Hemolytic-uremic syndrome caused by gemcitabine.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Fatal Outcome; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1998 |
Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Humans; Hyponatremia; Ifosfamide; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Tumor Lysis Syndrome; Vindesine | 2000 |
Establishment of the standard regimen for non-small-cell lung cancer in Japan.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Irinotecan; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Vindesine | 2001 |
[ Early anti-cancer drugs].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Vinblastine; Vindesine | 2002 |
Fotemustine: an overview of its clinical activity in disseminated malignant melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Remission Induction; Vindesine | 1992 |
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Remission Induction; Survival Rate; Vindesine | 1990 |
[Chemotherapy in non-small cell bronchial carcinoma. 12 years' experience in an international cooperative group: EORTC Lung Cancer Working Party].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Vindesine | 1990 |
Vinca alkaloids in the treatment of non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Humans; Lung Neoplasms; Random Allocation; Vinblastine; Vinca Alkaloids; Vincristine; Vindesine | 1987 |
Chemotherapy of non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Tolerance; Etoposide; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Vindesine | 1985 |
208 trial(s) available for vindesine and Lung Neoplasms
| Article | Year |
|---|---|
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Taxoids; Vindesine | 2010 |
Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Radiotherapy, Adjuvant; Vindesine | 2010 |
Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Japan; Lung Neoplasms; Male; Mitomycin; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vindesine | 2011 |
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Prospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2002 |
[Comparison of NP and MVP regimen in treatment of advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Treatment Outcome; Vincristine; Vindesine | 2002 |
[Clinical observation on effect of chemotherapy combined with Chinese medicine in treating advanced tumor patients and on immunologic parameters].
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Cisplatin; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Killer Cells, Natural; Lung Neoplasms; Male; Middle Aged; Mitomycin; Phytotherapy; Stomach Neoplasms; Vindesine | 2001 |
A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Preoperative Care; Prospective Studies; Remission Induction; Survival Analysis; Treatment Outcome; Vindesine | 2003 |
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Gemcitabine; Humans; Karnofsky Performance Status; Lung Neoplasms; Pain; Quality of Life; Time Factors; Treatment Outcome; Vindesine | 2003 |
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Patient Compliance; Patient Selection; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome; Vindesine | 2003 |
Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.
Topics: Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Diarrhea; Drug Administration Schedule; Female; Humans; Irinotecan; Linear Models; Lung Neoplasms; Male; Middle Aged; Nausea; Quality of Life; Vindesine; Vomiting, Anticipatory | 2003 |
Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Quality of Life; Survival Analysis; Taxoids; Vindesine | 2004 |
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Survival Rate; Vinblastine; Vindesine; Vinorelbine | 2004 |
A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Treatment Outcome; Vindesine | 2004 |
Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Dyspnea; Etoposide; Female; Health Status; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Quality of Life; Vindesine | 2004 |
[Prospective randomized study of HMVP, MVP, and HVP regimens in treatment of advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prospective Studies; Vindesine | 2004 |
Irinotecan in advanced lung cancer: focus on North American trials.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Deoxycytidine; Enzyme Inhibitors; Etoposide; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; North America; Radiotherapy, Adjuvant; Ribonucleotide Reductases; Survival Rate; Taxoids; Topoisomerase I Inhibitors; Vindesine | 2004 |
[Activity of toremifene plus mitomycin, vindesin and cisplatin regimen in unresectable non-small cell lung cancer].
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Division; Cisplatin; Female; Follow-Up Studies; Humans; Inhibitory Concentration 50; Lung Neoplasms; Male; Middle Aged; Mitomycins; Survival Rate; Toremifene; Tumor Cells, Cultured; Vindesine | 2004 |
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cohort Studies; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Multivariate Analysis; Nausea; Neoplasm Staging; Prospective Studies; Survival Analysis; Treatment Outcome; Vindesine; Vomiting | 2004 |
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Survival Analysis; Thoracotomy; Treatment Outcome; Vinblastine; Vindesine | 2005 |
Sequential administration of docetaxel followed by cisplatin-vindesine: a pilot study in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Taxoids; Vindesine | 2005 |
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Radiotherapy; Time Factors; Treatment Outcome; Vindesine | 2005 |
Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Analysis; Tegafur; Vindesine | 2005 |
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Epirubicin; Female; Humans; Incidence; L-Lactate Dehydrogenase; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Prognosis; Prospective Studies; Receptors, Estrogen; Risk Factors; Vindesine | 2005 |
Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Time Factors; Treatment Outcome; Vindesine | 2006 |
Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Prognosis; Vinblastine; Vindesine | 1983 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
A randomized prospective study of vindesine versus doxorubicin and cyclophosphamide in the treatment of epidermoid lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Random Allocation; Vinblastine; Vindesine | 1983 |
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Mitoguazone; Vinblastine; Vindesine | 1984 |
[Chemotherapy of carcinoma of the respiratory and digestive tracts with vindesine sulfate. Phase II clinical trial].
Topics: Aged; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Digestive System Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Respiratory Tract Neoplasms; Vinblastine; Vindesine | 1984 |
[Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Vinblastine; Vindesine | 1984 |
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine | 1984 |
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Random Allocation; Vinblastine; Vindesine | 1984 |
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Random Allocation; Time Factors; Vinblastine; Vindesine | 1981 |
Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kidney; Lung Neoplasms; Male; Middle Aged; Nervous System; Vinblastine; Vindesine | 1982 |
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Platinum; Vindesine | 1993 |
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Survival Rate; Treatment Outcome; Vindesine | 1995 |
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Retrospective Studies; Survival Rate; Vindesine | 1995 |
[Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate; Vindesine | 1995 |
Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Health Care Costs; Humans; Lung Neoplasms; Middle Aged; Survival Rate; Vinblastine; Vindesine; Vinorelbine | 1995 |
Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Palliative Care; Prospective Studies; Radiotherapy, High-Energy; Survival Analysis; Survival Rate; Vindesine | 1993 |
[Combination of cisplatin-mitomycin-vindesine for inoperable, non-small-cell bronchial cancers. French study group in pneumo-cancerology].
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Heart Diseases; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Staging; Palliative Care; Peripheral Nervous System Diseases; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Vindesine; Weight Loss | 1993 |
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Prognosis; Survival Analysis; Vindesine | 1994 |
Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Japan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Prospective Studies; Regression Analysis; Remission Induction; Survival Rate; Thrombocytopenia; Vindesine | 1995 |
Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Carcinoma, Non-Small-Cell Lung; Cisplatin; DNA Damage; DNA, Neoplasm; Female; Gene Amplification; Humans; Hypoxanthine Phosphoribosyltransferase; Leukocytes, Mononuclear; Lung Neoplasms; Male; Middle Aged; Mitomycins; Molecular Sequence Data; Pilot Projects; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity; Treatment Outcome; Vindesine | 1995 |
[Role of radiotherapy in the framework of curative chemotherapy concept in local advanced non-small-cell bronchial carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Mitomycins; Prospective Studies; Time Factors; Vindesine | 1995 |
Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncologie Th
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Radiotherapy; Survival Rate; Treatment Failure; Vindesine | 1995 |
Efficacy of famotidine in patients with acute gastric mucosal injury after continuous infusion of cisplatin plus vindesine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Flow Velocity; Carcinoma, Non-Small-Cell Lung; Cisplatin; Double-Blind Method; Drug Administration Schedule; Duodenum; Famotidine; Female; Gastric Juice; Gastric Mucosa; Hexosamines; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Intestinal Mucosa; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Stomach Ulcer; Treatment Outcome; Vindesine | 1995 |
[A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fever; Humans; Injections, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine; Vinorelbine | 1995 |
[A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Europe; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Analysis; Vinblastine; Vindesine; Vinorelbine | 1994 |
A randomised trial of vindesine plus interferon-alpha 2b compared with interferon-alpha 2b or vindesine alone in the treatment of advanced malignant melanoma.
Topics: Combined Modality Therapy; Female; Humans; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Recombinant Proteins; Soft Tissue Neoplasms; Vindesine | 1994 |
Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Delivery Systems; Humans; Lung Neoplasms; Middle Aged; Phosphoramide Mustards; Postoperative Care; Prognosis; Survival Analysis; Vindesine | 1994 |
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Topics: Aged; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Humans; Infusions, Intravenous; Lung Neoplasms; Middle Aged; Remission Induction; Survival Rate; Vinblastine; Vindesine; Vinorelbine | 1994 |
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working Party.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Death, Sudden, Cardiac; Fluorouracil; Heart; Humans; Lung Neoplasms; Mitomycins; Remission Induction; Survival Rate; Vindesine | 1994 |
[A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pilot Projects; Vindesine | 1993 |
[Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Survival Rate; Vincristine; Vindesine | 1994 |
Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy; Survival Analysis; Treatment Outcome; Vindesine | 1994 |
A phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1993 |
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Humans; Life Tables; Lomustine; Lung Neoplasms; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Vindesine | 1994 |
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Europe; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 1994 |
Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Diarrhea; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Vindesine | 1994 |
Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Granulocytes; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Recombinant Proteins; Vindesine | 1994 |
Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis; Vindesine | 1994 |
MICE: a new active combination for non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Vindesine | 1993 |
Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques)
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vindesine | 1993 |
Phase II study of carboplatin, cisplatin, and vindesine in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1993 |
Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Survival Analysis; Vindesine | 1993 |
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Verapamil; Vindesine | 1993 |
Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Survival Analysis; Vindesine | 1993 |
Cisplatin-mitomycin and vindesine in the treatment of inoperable non-small cell lung cancer groupe français de pneumo-cancérologie (GFPC)
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prospective Studies; Vindesine | 1993 |
Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Survival Analysis; Vindesine | 1993 |
Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diaphragm; Female; Humans; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Pleural Neoplasms; Prognosis; Vindesine | 1995 |
[Concurrent high-dose thoracic irradiation plus daily low-dose cisplatin and vindesine in locally advanced unresectable stage III non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Remission Induction; Survival Analysis; Vindesine | 1996 |
Optimal schedule for administering granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neutropenia; Prospective Studies; Recombinant Proteins; Vindesine | 1996 |
A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Time Factors; Vindesine | 1996 |
Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Neutropenia; Prospective Studies; Remission Induction; Vindesine | 1995 |
Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Epirubicin; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Vindesine | 1996 |
Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Prospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Vindesine | 1996 |
Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Radiotherapy Dosage; Survival Rate; Time Factors; Vindesine | 1996 |
[Evaluation of chemotherapy for stage IV non-small cell lung cancer employing a regression tree type method for quality-adjusted survival analysis to determine prognostic factors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Fluorouracil; Humans; Ifosfamide; Length of Stay; Lung Neoplasms; Male; Middle Aged; Prognosis; Quality of Life; Regression Analysis; Survival Analysis; Vindesine | 1996 |
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Palliative Care; Survival Rate; Vinblastine; Vindesine | 1996 |
Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Staging; Retrospective Studies; Survival Rate; Vinblastine; Vindesine; Vinorelbine | 1996 |
Cost analysis of hospital treatment--two chemotherapic regimens for non-surgical non-small cell lung cancer. GFPC (Groupe Français Pneumo Cancérologie)
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Direct Service Costs; Drug Costs; Female; France; Health Services Research; Hospital Costs; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Models, Economic; Oncology Service, Hospital; Prospective Studies; Quality-Adjusted Life Years; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 1996 |
Randomised trial of vindesine and etoposide +/- dexverapamil in advanced non-small cell lung cancer: first results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Calcium Channel Blockers; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Verapamil; Vindesine | 1995 |
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Europe; Female; Humans; Ifosfamide; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Remission Induction; Survival Rate; Vindesine | 1996 |
[A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Picibanil; Prospective Studies; Survival Rate; Tegafur; Uracil; Vindesine | 1996 |
Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chi-Square Distribution; Cisplatin; Confidence Intervals; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Rate; Time Factors; Vindesine; Weight Loss | 1995 |
[Effect of timing of granulocyte-colony stimulating factor administration on leukopenia induced by systemic chemotherapy in patients with non-small-cell lung cancer--multi-center randomized crossover study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cross-Over Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Mitomycin; Time Factors; Vindesine | 1996 |
A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vindesine | 1996 |
Adjuvant chemo-immunotherapy after curative resection of Stage II and IIIA primary lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Prospective Studies; Vindesine | 1996 |
Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Regression Analysis; Survival Rate; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 1996 |
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Survival Rate; Treatment Outcome; Vindesine | 1996 |
Cisplatin, mitomycin, and vindesine followed by intraoperative and postoperative radiotherapy for stage III non-small cell lung cancer: final results of a phase II study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Staging; Postoperative Care; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vindesine | 1997 |
[A study on treatment of lung cancer by combined therapy of traditional Chinese medicine and chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Diagnosis, Differential; Drugs, Chinese Herbal; Etoposide; Female; Humans; Lung Neoplasms; Male; Medicine, Chinese Traditional; Middle Aged; Mitomycin; Survival Rate; Vindesine | 1996 |
Phase II trial of dose intensification with cisplatin and carboplatin plus vindesine in patients with inoperable non-small cell lung cancer.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Recombinant Proteins; Remission Induction; Safety; Survival Rate; Thrombocytopenia; Vindesine; Vomiting | 1997 |
Efficacy of platinum-based regimens in non-small cell lung cancer. A negative report from the Cuneo Lung Cancer Study Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Quality of Life; Vindesine | 1997 |
Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Radiation-Sensitizing Agents; Vinblastine; Vindesine; Vinorelbine | 1997 |
[Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vinblastine; Vindesine | 1997 |
[Neoadjuvant combined therapy in stage IIIA if non-small-cell bronchial cancer].
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Dimethoate; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vindesine | 1997 |
Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Neoplasms; Mitomycin; Retrospective Studies; Vindesine | 1997 |
[Results of phase II clinical trial of vindesine in the treatment of malignant tumors].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Female; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Prospective Studies; Vindesine | 1996 |
A phase III randomized trial of cisplatin plus vindesine versus cisplatin plus vindesine plus mitomycin C versus cisplatin plus vindesine plus ifosfamide for advanced non-small-cell lung cancer.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine | 1996 |
Advanced non-small cell lung cancer chemotherapy: a randomized trial of two active regimens (MVP and PE).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Treatment Outcome; Vindesine | 1997 |
Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Mitomycin; Multivariate Analysis; Palliative Care; Survival Rate; Treatment Outcome; Vindesine | 1998 |
[Comparative study on quality of life between weekly and monthly chemotherapy with cisplatin, vindesine and mitomycin C in patients with non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Vindesine | 1998 |
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vinblastine; Vindesine | 1998 |
Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Staging; Radiotherapy Dosage; Survival Analysis; Survival Rate; Vindesine | 1998 |
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Nausea; Prospective Studies; Regression Analysis; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vindesine; Vomiting | 1998 |
Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Platinum; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vindesine | 1998 |
Induction chemotherapy for T4 centrally located non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pneumonectomy; Preoperative Care; Prospective Studies; Vindesine | 1999 |
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycins; Prospective Studies; Vindesine | 1998 |
Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Quality of Life; Vindesine | 1999 |
Cost utility of chemotherapy and best supportive care in non-small cell lung cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Humans; Lung Neoplasms; Retrospective Studies; Survival Analysis; Vindesine | 1995 |
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Quality of Life; Vinblastine; Vindesine; Vinorelbine | 1999 |
Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Postoperative Period; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Vindesine | 1999 |
Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Platinum; Pneumonectomy; Prognosis; Prospective Studies; Remission Induction; Survival Analysis; Survival Rate; Vindesine | 1999 |
[Anti-emetic treatment for patients with non-small cell lung cancer after chemotherapy, usefulness of preventive combination of anti-emetic agents and importance of psychiatric aspect of patients].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Lung Neoplasms; Male; Methylprednisolone; Metoclopramide; Middle Aged; Mitomycin; Personality; Vindesine; Vomiting, Anticipatory | 1999 |
Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Survival Rate; Vinblastine; Vindesine | 1999 |
[Effect of preoperative chemotherapy for bulky N2 non-small-cell lung cancer].
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Preoperative Care; Survival Rate; Vindesine | 1999 |
A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pulmonary Fibrosis; Radiotherapy; Radiotherapy Dosage; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome; Vindesine | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Prospective Studies; Recurrence; Survival Analysis; Vindesine | 1999 |
[An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Vindesine | 2000 |
Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis; Vindesine | 2000 |
A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA (N2) non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Survival Analysis; Treatment Outcome; Vindesine | 2000 |
Feasibility and preliminary results of intensive chemotherapy and extensive irradiation in selected patients with limited small-cell lung carcinoma--results of three consecutive phase II programs.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis; Treatment Outcome; Vindesine | 2000 |
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Recurrence; Survival Analysis; Vindesine | 2000 |
Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Prospective Studies; Survival Analysis; Treatment Outcome; Vindesine | 2000 |
Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2001 |
Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; Vindesine | 2001 |
Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose Fractionation, Radiation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Rate; Vindesine | 2001 |
Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis; Treatment Outcome; Vindesine | 2001 |
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Endpoint Determination; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Rate; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vindesine | 2001 |
Phase II study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindesine for unresectable stage III non-small-cell lung cancer: Japan Clinical Oncology Group Study 9306.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Vindesine | 2002 |
Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Carcinoma, Non-Small-Cell Lung; Cisplatin; Double-Blind Method; Drug Administration Schedule; Erythropoietin; Female; Hemoglobins; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Recombinant Proteins; Treatment Outcome; Vindesine | 2001 |
Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Survival Rate; Vinblastine; Vindesine; Vinorelbine | 2001 |
[Clinical usefulness of ondansetron injection in patients receiving cancer chemotherapy].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Ondansetron; Ovarian Neoplasms; Retrospective Studies; Vindesine | 2002 |
A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Radiation Dosage; Survival Rate; Treatment Failure; Vindesine | 2002 |
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Cisplatin; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Proportional Hazards Models; Survival Analysis; Treatment Outcome; Vindesine | 2002 |
Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell lung cancer.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Survival Analysis; Vindesine | 1992 |
The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Cisplatin; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neutropenia; Time Factors; Vindesine | 1992 |
[Randomized trial of cisplatin plus ifosfamide versus cisplatin plus vindesine for non-small cell lung cancer (NSCLC)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vindesine | 1992 |
[Phase II trial of concomitant cyclic radio-chemotherapy combination (ARCCC) in unoperable non-small cell lung cancer (CBNPCI)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Lung Neoplasms; Radiation Dosage; Vindesine | 1992 |
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Staging; Pilot Projects; Remission Induction; Survival Analysis; Vindesine | 1992 |
Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Survival Analysis; Vindesine | 1992 |
[A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Vindesine | 1992 |
Carboplatin and vindesine in advanced non-small cell lung cancer. A feasibility study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1992 |
Phase II study of cisplatin continuous infusion plus vindesine in the treatment of non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Analysis; Vindesine | 1992 |
[Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis; Vindesine | 1992 |
Fotemustine: an overview of its clinical activity in disseminated malignant melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Remission Induction; Vindesine | 1992 |
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Fé
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vindesine | 1991 |
A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Staging; Prognosis; Vindesine | 1991 |
Sequential chemotherapy in good-prognosis patients with small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Vincristine; Vindesine | 1991 |
A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Proportional Hazards Models; Survival Rate; Vindesine | 1991 |
A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Vindesine | 1991 |
[Is chemotherapy with cisplatin useful in non small cell bronchial cancer at staging IV? Results of a randomized study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Vindesine | 1991 |
A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate; Vindesine | 1991 |
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Neoplasm Staging; Thrombocytopenia; Vindesine | 1991 |
Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vindesine | 1991 |
A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Palliative Care; Randomized Controlled Trials as Topic; Vindesine | 1990 |
[Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
Topics: Adenocarcinoma; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Colony-Stimulating Factors; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Vindesine | 1990 |
Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Staging; Peplomycin; Ploidies; Prognosis; Vindesine | 1991 |
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Vindesine | 1991 |
[Comparative study on vindesine plus cisplatin treatment of advanced non-small cell lung cancer--three divided doses (35 mg/m2, day 1, 8, 15) and single dose (80 mg/m2, day 1) of cisplatin. Chiba Lung Cancer Study Group].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Survival Rate; Vindesine; Vomiting | 1991 |
Phase III trial with and without lonidamine in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Prospective Studies; Remission Induction; Survival Rate; Time Factors; Vindesine | 1991 |
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vindesine | 1990 |
Two cycles of cisplatin-vindesine and radiotherapy for localized nonsmall cell carcinoma of the lung (stage III). Results of a prospective trial with 149 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cause of Death; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiation Injuries; Randomized Controlled Trials as Topic; Respiration Disorders; Survival Rate; Vindesine | 1990 |
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Remission Induction; Survival Rate; Vindesine | 1990 |
[Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Regression Analysis; Remission Induction; Sex Factors; Survival Rate; Vindesine | 1990 |
Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Multicenter Studies as Topic; Neutropenia; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; United States; Vindesine | 1990 |
Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Survival Rate; Vindesine | 1990 |
Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma. Results from a randomized phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Random Allocation; Survival Rate; Vindesine | 1990 |
Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiation Injuries; Randomized Controlled Trials as Topic; Survival Rate; Vindesine | 1990 |
[Current results of chemotherapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Survival Rate; Vindesine | 1990 |
[Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Prospective Studies; Randomized Controlled Trials as Topic; Vindesine | 1990 |
Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Government Agencies; Hospitalization; Humans; Life Support Care; Lung Neoplasms; Randomized Controlled Trials as Topic; Retrospective Studies; Vindesine | 1990 |
Phase II study of 5-day continuous infusion of cis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Evaluation; Humans; Infusions, Intravenous; Lung Neoplasms; Radiotherapy Dosage; Remission Induction; Time Factors; Vindesine | 1990 |
[Chemotherapy in non-small cell bronchial carcinoma. 12 years' experience in an international cooperative group: EORTC Lung Cancer Working Party].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Vindesine | 1990 |
Cisplatin and vindesine for disseminated non-small cell lung cancer. Results of a prospective trial with 81 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Vindesine | 1990 |
[A randomized controlled study of PSK combined immuno-chemotherapy for adenocarcinoma of the lung. The Advanced Lung Cancer Immuno-chemotherapy Study Group].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Immunotherapy; Lung Neoplasms; Male; Middle Aged; Proteoglycans; Randomized Controlled Trials as Topic; Vindesine | 1990 |
The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Nimustine; Nitrosourea Compounds; Peplomycin; Prognosis; Random Allocation; Vincristine; Vindesine | 1987 |
Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine.
Topics: Adenocarcinoma; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Humans; Kidney; Lung Neoplasms; Platinum; Random Allocation; Thiosulfates; Time Factors; Vindesine | 1989 |
Chemotherapy of advanced non-small-cell lung cancer: a randomized trial of three cis-platin-based chemotherapy regimens.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Lung Neoplasms; Middle Aged; Prospective Studies; Random Allocation; Vindesine | 1989 |
A comparison of cis-platinum-vindesine and cis-platinum-etoposide combined with radiotherapy for previously untreated localized inoperable non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Vindesine | 1989 |
[A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Random Allocation; Vindesine | 1987 |
Vincristine-cyclophosphamide, the classical two-drug regimen for small-cell lung cancer, evaluated in a randomized study with vindesine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Random Allocation; Vincristine; Vindesine | 1987 |
A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Female; Humans; Lung Neoplasms; Male; Methotrexate; Random Allocation; Vindesine | 1987 |
[Results of 2 multicenter therapy studies in inoperable non-small cell bronchial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vindesine | 1988 |
Chemotherapy for non-small cell lung cancer: a randomized trial of cisplatin/vindesine v no chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Random Allocation; Vindesine; Vomiting | 1988 |
[Phase III therapy study in patients with small cell bronchial cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Random Allocation; Vindesine | 1988 |
Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Random Allocation; Vindesine | 1988 |
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Random Allocation; Vinblastine; Vindesine | 1985 |
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Creatinine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Peripheral Nervous System Diseases; Thrombocytopenia; Vinblastine; Vindesine | 1985 |
Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Nausea; Time Factors; Vinblastine; Vindesine | 1985 |
Vindesine and mitomycin in the treatment of advanced non-small cell lung cancer: a Southeastern Cancer Study Group Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Mitomycins; Peripheral Nervous System Diseases; Vindesine | 1986 |
[Combination chemotherapy and radiotherapy in small cell carcinoma of the lung].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Nimustine; Nitrosourea Compounds; Prognosis; Vincristine; Vindesine | 1986 |
Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Humans; Lung Neoplasms; Middle Aged; Vindesine | 1986 |
[A randomized comparison of radiotherapy with CAP and CVP in non-small cell lung cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Random Allocation; Vindesine | 1986 |
Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Random Allocation; Thrombocytopenia; Uremia; Vindesine | 1986 |
Cisplatin plus vindesine versus cisplatin plus VP16 versus doxorubicin plus cytoxan in non-small-cell carcinoma of the lung. A randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lung Neoplasms; Middle Aged; Podophyllotoxin; Random Allocation; Vindesine | 1986 |
Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Prognosis; Vincristine; Vindesine | 1987 |
Two randomized trials for alternating polychemotherapy of small cell lung cancer.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Random Allocation; Sex Factors; Smoking; Time Factors; Vincristine; Vindesine | 1986 |
Vinca alkaloids in the treatment of non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Humans; Lung Neoplasms; Random Allocation; Vinblastine; Vinca Alkaloids; Vincristine; Vindesine | 1987 |
Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Drug Evaluation; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Random Allocation; Vindesine | 1987 |
Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Mitomycins; Prospective Studies; Random Allocation; Vindesine | 1986 |
[Restorative effect of muroctasin, MDP-Lys (L 18), on leukopenia caused by anticancer chemotherapy in lung cancer--comparative study by envelope method].
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Vincristine; Vindesine | 1988 |
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Random Allocation; Vinblastine; Vindesine | 1986 |
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Vindesine | 1986 |
Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Clinical Trials as Topic; Follow-Up Studies; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasm Metastasis; Vindesine | 1986 |
Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platelet Count; Random Allocation; Vinblastine; Vindesine | 1985 |
215 other study(ies) available for vindesine and Lung Neoplasms
| Article | Year |
|---|---|
Prognostic implications of diffusion-weighted magnetic resonance imaging in patients with superior sulcus tumors receiving induction chemoradiation therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Humans; Induction Chemotherapy; Infusions, Intravenous; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Prognosis; Thoracotomy; Tomography, X-Ray Computed; Treatment Outcome; Vindesine | 2016 |
Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Calcium Channel Blockers; Cell Proliferation; Cisplatin; Dose Fractionation, Radiation; Doxorubicin; Drug Resistance, Neoplasm; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Radiation Tolerance; Spheroids, Cellular; Tumor Cells, Cultured; Verapamil; Vindesine; X-Rays | 2009 |
Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Radiotherapy; Remission Induction; Survival Analysis; Treatment Outcome; Vindesine | 2009 |
Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Feasibility Studies; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Radiotherapy; Survival Rate; Vindesine | 2002 |
Induction chemotherapy before operation for multiple endobronchial squamous cell carcinoma of the lung.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Treatment Outcome; Vindesine | 2002 |
[Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Poland; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Time Factors; Vindesine | 2002 |
[Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Lung Neoplasms; Mitomycin; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2002 |
[Cost-effectiveness analysis: a reader's guide].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cost-Benefit Analysis; Data Interpretation, Statistical; Evidence-Based Medicine; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine; Vinorelbine | 2003 |
[Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Postoperative Period; Radiotherapy Dosage; Retrospective Studies; Vindesine | 2003 |
Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Drug Approval; Drug Combinations; France; Humans; Infusions, Intravenous; Lung Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Survival Rate; Taxoids; Treatment Outcome; Vinblastine; Vindesine | 2005 |
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Treatment Outcome; Vindesine | 2005 |
Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Outcome; Vindesine | 1989 |
Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 2006 |
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Empyema, Pleural; Female; Forced Expiratory Volume; Forecasting; Humans; Hypoxia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Pneumonia; Postoperative Complications; Predictive Value of Tests; Pulmonary Atelectasis; Pulmonary Diffusing Capacity; Pulmonary Embolism; Pulmonary Gas Exchange; Radiotherapy; Remission Induction; Respiratory Distress Syndrome; Respiratory Insufficiency; Retrospective Studies; Risk Factors; Vinblastine; Vindesine; Vinorelbine; Vital Capacity | 2006 |
Prognostic significance of p21 protein expression in patients with pulmonary squamous cell carcinoma following induction chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Humans; Immunohistochemistry; Lung Neoplasms; Middle Aged; Neoplasm Staging; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome; Tumor Burden; Tumor Suppressor Protein p53; Vindesine | 2007 |
[3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Vinblastine; Vincristine; Vindesine | 1984 |
Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1984 |
Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1984 |
[Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Vinblastine; Vindesine | 1984 |
Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Drug Resistance; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Vinblastine; Vindesine | 1984 |
Evaluation of vindesine in patients with refractory small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1984 |
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Kidney Diseases; Lung Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Vinblastine; Vindesine | 1983 |
Mitomycin-associated lung disease.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Cisplatin; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Mitomycins; Vinblastine; Vincristine; Vindesine | 1983 |
Prospective study of follow up alone in stage I teratoma of the testis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Castration; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Prednisolone; Prospective Studies; Teratoma; Testicular Neoplasms; Vinblastine; Vindesine | 1983 |
[The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carbazilquinone; Carcinoembryonic Antigen; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Peplomycin; Vinblastine; Vincristine; Vindesine | 1984 |
Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Palliative Care; Prognosis; Vinblastine; Vindesine | 1984 |
Progress in chemotherapy of non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Prognosis; Random Allocation; Vinblastine; Vindesine | 1984 |
[Platelet aggregation and coenzyme Q10 content in platelets in cancer patients].
Topics: Adult; Aged; beta-Thromboglobulin; Blood Platelets; Chromatography, High Pressure Liquid; Coenzymes; Collagen; Epinephrine; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Platelet Aggregation; Platelet Count; Ubiquinone; Vinblastine; Vindesine | 1984 |
Carcinoma metastatic to the anterior ocular segment: response to chemotherapy.
Topics: Aged; Carcinoma, Small Cell; Eye Neoplasms; Humans; Iris; Lung Neoplasms; Male; Vinblastine; Vindesine | 1980 |
Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Vinblastine; Vindesine | 1982 |
A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine.
Topics: Adenocarcinoma; Animals; Carcinoma, Small Cell; Cell Division; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Neoplasms, Experimental; Vinblastine; Vincristine; Vindesine | 1982 |
Vindesine in bronchogenic carcinoma: a phase II trial.
Topics: Adenocarcinoma; Aged; Anemia; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cellulitis; Drug Evaluation; Humans; Lung Neoplasms; Middle Aged; Nervous System; Phlebitis; Thrombocytosis; Vinblastine; Vindesine | 1982 |
A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drug Evaluation; Drug Resistance; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nervous System; Vinblastine; Vindesine | 1982 |
Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
Topics: Altretamine; Antineoplastic Agents; Carcinoma, Small Cell; Drug Therapy, Combination; Humans; Leukocyte Count; Liver Neoplasms; Lung Neoplasms; Male; Mitomycins; Vinblastine; Vindesine | 1982 |
Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Podophyllotoxin; Vinblastine; Vincristine; Vindesine | 1982 |
Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.
Topics: Aged; Cisplatin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kinetics; Leukopenia; Lung Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Thrombocytopenia; Vinblastine; Vindesine | 1983 |
Vindesine in the treatment of squamous cell carcinoma (WHO I), adenocarcinoma (WHO III), and large cell carcinoma (WHO IV) of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1982 |
[Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Vinblastine; Vindesine | 1982 |
Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Paresthesia; Vinblastine; Vindesine | 1983 |
Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Evaluation; Humans; Immune Tolerance; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Vinblastine; Vindesine | 1984 |
[Chemotherapy of advanced non-small cell bronchogenic carcinoma with cisplatin and vindesine].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1984 |
Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cisplatin; Dogs; Drug Administration Schedule; Drug Evaluation; Etoposide; Hematologic Diseases; Humans; Lung Neoplasms; Middle Aged; Time Factors; Vinblastine; Vindesine | 1984 |
Warfarin, etoposide, and vindesine interactions.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Interactions; Etoposide; Humans; Lung Neoplasms; Male; Prothrombin Time; Vinblastine; Vindesine; Warfarin | 1984 |
[Cis-dichlorodiammine platinum (II) CDDP in the treatment of non-small cell lung cancer].
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1984 |
[Combination chemotherapy of primary adenocarcinoma of the lung using adriamycin, ACNU, and vindesine].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Nimustine; Nitrosourea Compounds; Vinblastine; Vindesine | 1983 |
[A cooperative phase II study of vindesine sulfate in patients with solid tumors].
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Child; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Vinblastine; Vindesine | 1983 |
Phase II trial of vindesine in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nervous System; Neutropenia; Vinblastine; Vindesine | 1984 |
Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
Topics: Adult; Aged; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nervous System Diseases; Skin Neoplasms; Thrombocytopenia; Vinblastine; Vindesine | 1984 |
[Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Drug Evaluation; Female; Humans; Infusions, Parenteral; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Vinblastine; Vindesine | 1983 |
Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1982 |
Vindesine overdose.
Topics: Aged; Antineoplastic Agents; Humans; Lung Neoplasms; Male; Vinblastine; Vindesine | 1982 |
Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Body Weight; Carcinoma, Squamous Cell; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nervous System; Neutropenia; Prognosis; Vinblastine; Vindesine | 1982 |
Vindesine: an effective agent in the treatment of non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Alopecia; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1982 |
Investigation of the in vivo anti-invasive and anti-metastatic effect of desacetyl vinblastine amide sulphate or vindesine.
Topics: Animals; Leukemia P388; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Invasiveness; Neoplasm Metastasis; Vinblastine; Vindesine | 1982 |
A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro.
Topics: Antineoplastic Agents; Carcinoembryonic Antigen; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Immunoglobulins; Lung Neoplasms; Uridine; Vinblastine; Vindesine | 1981 |
Vindesine chemotherapy in lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nervous System Diseases; Vinblastine; Vindesine | 1980 |
Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma: preliminary results.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Cyclophosphamide; Humans; Lung Neoplasms; Vinblastine; Vincristine; Vindesine | 1980 |
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; CD57 Antigens; Cell Differentiation; Chromogranin A; Chromogranins; Cisplatin; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Immunologic Factors; Interferons; Karnofsky Performance Status; Life Tables; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Proteins; Neoplasm Staging; Phosphopyruvate Hydratase; Prognosis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Survival Rate; Synaptophysin; Vindesine | 1993 |
[Lung fibrosis after bleomycin therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Hodgkin Disease; Humans; Lung Neoplasms; Male; Mechlorethamine; Prednisone; Procarbazine; Pulmonary Fibrosis; Vincristine; Vindesine | 1994 |
Cost-effectiveness analysis: sleeping with an enemy or a friend?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Drug Industry; Fees and Charges; Health Care Costs; Humans; Lung Neoplasms; Research Support as Topic; Vinblastine; Vindesine; Vinorelbine | 1995 |
[A case of lung cancer with choroidal metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Choroid Neoplasms; Cisplatin; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Mitomycin; Vindesine | 1995 |
The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function.
Topics: Adult; Aged; Aged, 80 and over; Aging; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Regression Analysis; Vindesine | 1995 |
Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Radiotherapy Dosage; Survival Analysis; Vindesine | 1995 |
[Antitumor activity of combination treatment combining gemcitabine with cisplatin or vindesine against human lung cancer xenografted in nude mice].
Topics: Adenocarcinoma, Papillary; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cisplatin; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Vindesine | 1994 |
Transient neutropenia after intravenous injection of vindesine in patients with lung cancer.
Topics: Animals; Female; Humans; In Vitro Techniques; Leukocyte Count; Lung Neoplasms; Lymphocytes; Male; Middle Aged; Neutropenia; Neutrophils; Rats; Rats, Wistar; Vindesine | 1994 |
[Acquired resistance and cross-resistance of gemcitabine to cisplatin or vindesine in human lung cancer xenografted in nude mice].
Topics: Adenocarcinoma, Papillary; Animals; Cell Division; Cisplatin; Deoxycytidine; Drug Resistance; Gemcitabine; Humans; Lung Neoplasms; Mice; Mice, Nude; Transplantation, Heterologous; Vindesine | 1994 |
Lung cancer found in a patient with absence of the inferior vena cava associated with a left superior vena cava.
Topics: Aged; Angiography, Digital Subtraction; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Congenital Abnormalities; Humans; Lung Neoplasms; Lymph Node Excision; Male; Mitomycin; Pneumonectomy; Tomography, X-Ray Computed; Venae Cavae; Vindesine | 1994 |
Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Incidence; Length of Stay; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Mitomycins; Neoplasm Staging; Pneumonectomy; Postoperative Complications; Proportional Hazards Models; Remission Induction; Survival Rate; Time Factors; Vinblastine; Vindesine; Vinorelbine | 1994 |
[Experimental evaluation of combination chemotherapy with UFT and cisplatin for lung cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Mice; Neoplasm Transplantation; Tegafur; Uracil; Vindesine | 1994 |
Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lethal Dose 50; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; Transplantation, Heterologous; Vinblastine; Vindesine; Vinorelbine | 1993 |
Recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Time Factors; Vindesine | 1993 |
Concurrent carboplatin (CBDCA), vindesine (VDS) and radiotherapy in stage III non small cell lung cancer (NSCLC).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Feasibility Studies; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Vindesine | 1993 |
Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Pneumonectomy; Survival Rate; Time Factors; Vinblastine; Vindesine | 1993 |
Characterisation of a vindesine-resistant human small-cell lung cancer cell line.
Topics: Antineoplastic Agents; Blotting, Northern; Blotting, Western; Carcinoma, Small Cell; Cell Division; Clone Cells; Drug Resistance; Humans; Kinetics; Lung Neoplasms; RNA, Neoplasm; Tubulin; Tumor Cells, Cultured; Verapamil; Vindesine | 1993 |
Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine | 1993 |
[Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin].
Topics: Adenocarcinoma; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granisetron; Humans; Indazoles; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Nausea; Vindesine; Vomiting | 1993 |
Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Europe; Humans; Lung Neoplasms; Randomized Controlled Trials as Topic; Survival Rate; United States; Value of Life; Vinblastine; Vindesine; Vinorelbine; Virginia | 1996 |
Disease extent and response to chemotherapy in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Remission Induction; Survival Rate; Vindesine | 1996 |
Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: a case report of long-term survival.
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Pleura; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurisy; Pneumonectomy; Survival Rate; Vindesine | 1996 |
Histopathological grading of response to induction chemotherapy in non-small cell lung cancer: a preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Vindesine | 1996 |
[A case of lung adenocarcinoma associated with remarkably high levels of CA 19-9 and lymphangitis carcinomatosa].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Cisplatin; Humans; Lung Neoplasms; Lymphangitis; Male; Pleural Effusion, Malignant; Vindesine | 1997 |
A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neurologic Examination; Pilot Projects; Prognosis; Regression Analysis; Severity of Illness Index; Survival Rate; Vindesine | 1997 |
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1997 |
[The usefulness of fibrin glue spraying combined with CDDP for lung cancer].
Topics: Adenocarcinoma; Adult; Aerosols; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fibrin Tissue Adhesive; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Nebulizers and Vaporizers; Vindesine | 1997 |
Semi-quantitative assessment of 99Tcm-sestamibi uptake in lung cancer: relationship with clinical response to chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vindesine | 1997 |
Malignant blue nevus of the scalp.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Fatal Outcome; Humans; Interferon-alpha; Liver Neoplasms; Lung Neoplasms; Nevus, Blue; Scalp; Skin Neoplasms; Vindesine | 1998 |
[Endoscopic findings of esophagitis in concurrent chemo-radiotherapy for lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Esophagitis; Esophagoscopy; Etoposide; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Radiation Injuries; Radiotherapy; Vindesine | 1998 |
Vasospastic angina likely related to cisplatin-containing chemotherapy and thoracic irradiation for lung cancer.
Topics: Adenocarcinoma; Aged; Angina Pectoris, Variant; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Electrocardiography; Etoposide; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Myocardial Ischemia; Neoplasm Staging; Radiation Injuries; Radiotherapy; Vindesine | 1999 |
Increased levels of vascular endothelial growth factor in bronchoalveolar lavage of patients with bronchial carcinoma effect of tumour activity and oxidative stress due to radio-chemotherapy?
Topics: Adult; Aged; Aged, 80 and over; Albumins; Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Bronchoalveolar Lavage Fluid; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Deoxycytidine; Endothelial Growth Factors; Epidermal Growth Factor; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Lymphokines; Male; Middle Aged; Neoplasm Proteins; Neovascularization, Pathologic; Oxidative Stress; Proteins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vindesine | 1999 |
[A long-term survivor of extensive-stage small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Survivors; Vindesine | 2000 |
[Experience with induction chemoradiotherapy for cT4N2M0 lung cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Omentum; Pneumonectomy; Remission Induction; Vindesine | 2000 |
[Combination chemotherapy consisting of ifosfamide and vindesine for non-small cell lung cancer in the elderly].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Retrospective Studies; Treatment Outcome; Vindesine | 2000 |
[Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Vindesine | 2000 |
Antiangiogenic and antitumor effects of tranilast on mouse lung carcinoma cells.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cisplatin; Cyclohexanes; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; ortho-Aminobenzoates; Sesquiterpenes; Tumor Cells, Cultured; Vindesine | 2000 |
Chemotherapy for older people with non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Comorbidity; Female; Hospitalization; Humans; Lung Neoplasms; Male; Mitomycin; Prospective Studies; Survival Analysis; Vindesine | 2000 |
[Effectiveness of docetaxel plus cisplatin in large cell lung cancer showing little response to prior chemotherapy with MVP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Taxoids; Treatment Failure; Vindesine | 2000 |
[Postoperative complications after radiochemotherapy or chemotherapy for bronchial cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Fistula; Carcinoma, Bronchogenic; Cause of Death; Cisplatin; Etoposide; Female; Fluorouracil; Hospital Mortality; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pneumonectomy; Pneumonia; Radiotherapy, Adjuvant; Reoperation; Retrospective Studies; Risk Factors; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2000 |
[A case of primary malignant fibrous histiocytoma of the lung].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Vindesine | 2001 |
Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Northern; Carcinoma; DNA, Complementary; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Microtubule Proteins; Paclitaxel; Phosphoproteins; RNA, Messenger; Stathmin; Transfection; Tumor Cells, Cultured; Vincristine; Vindesine | 2001 |
[Treatment for elderly lung cancer patients by anticancer drugs and possible use of target based drugs].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Vindesine | 2001 |
Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Recurrence; Time Factors; Vindesine | 2001 |
[A comparative study between clinical response and pathologic changes to preoperative chemotherapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vindesine | 1999 |
[Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Vindesine | 1999 |
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cisplatin; Dacarbazine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Paclitaxel; Spinal Cord Neoplasms; Survivors; Taxoids; Vincristine; Vindesine | 2002 |
[Evaluation of chemotherapy of unresectable non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vindesine | 1992 |
[Advances in the treatment of non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Vindesine | 1992 |
A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy.
Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors; Sex Factors; Vindesine | 1992 |
Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vindesine | 1992 |
Pharmacokinetic study of mitomycin C with emphasis on the influence of aging.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Uterine Cervical Neoplasms; Vindesine | 1992 |
Renal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Hypokalemia; Hyponatremia; Kidney Diseases; Lung Neoplasms; Magnesium; Male; Middle Aged; Mitomycin; Vindesine; Water-Electrolyte Imbalance | 1992 |
Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Palliative Care; Survival Rate; Treatment Outcome; Vindesine | 1992 |
The role of three cisplatin-based chemotherapy regimens in the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies; Vincristine; Vindesine | 1992 |
Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Death; Cell Division; Cisplatin; DNA, Neoplasm; Humans; Lung Neoplasms; PC12 Cells; Tumor Cells, Cultured; Vinblastine; Vindesine; Vinorelbine | 1992 |
A phase II study of vindesine plus etoposide in metastatic non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Middle Aged; Vindesine | 1991 |
Necrotizing bronchial aspergillosis in a patient receiving neoadjuvant chemotherapy for non-small cell lung carcinoma.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Bronchi; Bronchial Diseases; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Itraconazole; Ketoconazole; Lung Neoplasms; Mitomycin; Mitomycins; Necrosis; Vindesine | 1991 |
[Assessment of a phase III trial of adjuvant chemotherapy in resected lung cancer: an imbalance of surgical results among cooperative institutions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Multicenter Studies as Topic; Survival Rate; Vindesine | 1991 |
Vindesine and etoposide chemotherapy in the management of patients with small cell lung cancer and poor prognosis.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Prognosis; Remission Induction; Retrospective Studies; Serum Albumin; Survival Rate; Vincristine; Vindesine | 1991 |
[Five-day continuous infusion of vindesine in the treatment of non-small cell lung cancer--clinical pharmacokinetics of vindesine].
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Vindesine | 1991 |
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Mitomycin; Neoplasm Staging; Remission Induction; Time Factors; Vindesine | 1991 |
Hypercoagulopathy induced by chemotherapy in a patient with lung cancer. A possible role for a factor with thrombosis-inducing activity (TIA).
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Lung Neoplasms; Male; Organoplatinum Compounds; Platelet Count; Tegafur; Thrombosis; Vindesine | 1992 |
[Effect of short-term administration of medroxyprogesterone acetate on side reactions of combination chemotherapy with ADR, VDS and CDDP in primary lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cisplatin; Doxorubicin; Drug Administration Schedule; Humans; Leukocyte Count; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Nausea; Vindesine; Vomiting | 1991 |
[Combined intra-arterial chemotherapy and radiotherapy in inoperable non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Middle Aged; Radiotherapy Dosage; Vindesine | 1991 |
[Cisplatin, doxorubicin and vindesine in the treatment of advanced non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Survival Rate; Vindesine | 1991 |
[The relation between myelotoxicity and performance status or aging in chemotherapy of non-small cell lung cancer].
Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Thrombocytopenia; Vindesine | 1991 |
[Successful treatment of metastatic and refractory osteosarcoma by ifosfamide, carboplatin and vindesine: case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Drug Administration Schedule; Humans; Ifosfamide; Lung Neoplasms; Male; Osteosarcoma; Vindesine | 1991 |
[Clinical evaluation of bronchial artery infusion (BAI) in lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Cisplatin; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Retrospective Studies; Survival Rate; Vindesine | 1991 |
[Cisplatin, ifosfamide and vindesine in the chemotherapy of squamous cell carcinoma of the lung].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Humans; Ifosfamide; Kidney; Lung Neoplasms; Survival Rate; Vindesine | 1991 |
[Cisplatin and vinca alkaloid combination chemotherapy of advanced non-small-cell lung cancer in the aged].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Vindesine | 1990 |
[Syndrome of inappropriate antidiuretic hormone secretion following cisplatinum and vindesine administration in a patient with squamous cell carcinoma of the lung].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Vindesine | 1991 |
Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Remission Induction; Taurine; Vindesine | 1990 |
Five-year survival of nonsmall-cell lung cancer patients after treatment with chemotherapy alone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Neoplasms; Vindesine | 1990 |
Phase II trial of cytarabine, cisplatin and vindesine for advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cytarabine; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1990 |
[Radiotherapy combined with cis-diammine-dichloro platinum (II) plus vindesine in the treatment of non-small cell lung cancer: a comparison with treatment by radiation alone].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Remission Induction; Survival Rate; Vindesine | 1990 |
[Phase II study of ifosfamide and vindesine combination of non-small cell lung cancer in elderly patients and patients with reduced renal function].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Ifosfamide; Kidney; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Vindesine | 1990 |
[Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prognosis; Vindesine | 1990 |
[Interstitial pneumonia developed after combination chemotherapy with (CDDP, VDS, MMC) and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Male; Mitomycin; Mitomycins; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy; Vindesine | 1990 |
[Surgical adjuvant therapy, especially neoadjuvant therapy of lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Preoperative Care; Prognosis; Survival Rate; Vindesine | 1990 |
[Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Vindesine | 1990 |
Initial tumor size and local control in stage III non-small cell lung cancer treated by radio-chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Rate; Vindesine | 1990 |
[Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Survival Rate; Thrombocytopenia; Vindesine | 1990 |
Effectiveness of treatment for non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Protocols; Combined Modality Therapy; Humans; Lung Neoplasms; Vindesine | 1990 |
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Vindesine | 1990 |
[A case of effective chemotherapy with CDDP and VDS for metastatic lesions of the lung and spleen and simultaneous resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Middle Aged; Parotid Neoplasms; Pneumonectomy; Remission Induction; Splenectomy; Splenic Neoplasms; Vindesine | 1990 |
[Current perspectives in the management of non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Vinblastine; Vincristine; Vindesine | 1985 |
Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dactinomycin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Vindesine | 1986 |
Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Patient Acceptance of Health Care; Quality of Life; Vindesine | 1986 |
[Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Peplomycin; Vindesine | 1988 |
[Bronchial arterial infusion chemotherapy (BAI) and BAI with radiotherapy in advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Arteries; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Peplomycin; Radiotherapy Dosage; Vindesine | 1988 |
[Beneficial effect of cisplatin based combination chemotherapy on adenocarcinoma of the lung].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Remission Induction; Retrospective Studies; Survival Rate; Vindesine | 1989 |
European experience with ifosfamide in non-small cell lung cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Europe; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Remission Induction; Vindesine | 1989 |
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Preoperative Care; Radiotherapy, High-Energy; Vindesine | 1989 |
Fractionated irradiation under ambient conditions of human NSCLC transplanted into nude mice: effect of different fractionation schedules and of radiotherapy and vindesine.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Radiotherapy Dosage; Transplantation, Heterologous; Vindesine | 1989 |
[Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Vindesine | 1989 |
[Effect of the pulmonary artery infusion chemotherapy of non-small cel lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Pulmonary Artery; Vindesine | 1989 |
[Pilot study of a continuous five-day intravenous infusion of cisplatin plus vindesine in advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Vindesine | 1989 |
Fatal acute interstitial pneumonia induced by low-dose doxorubicin and vindesine.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Doxorubicin; Female; Histocytochemistry; Humans; Lung Neoplasms; Middle Aged; Pulmonary Fibrosis; Vindesine | 1989 |
[Combination chemotherapy with bronchial arterial infusion (BAI) and systemic chemotherapy in advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Vindesine | 1989 |
[Effect of cisplatinum (CDDP) and combined chemotherapy with CDDP on peripheral blood lymphocyte natural killer (NK) activity].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cytotoxicity, Immunologic; Humans; Killer Cells, Natural; Lung Neoplasms; Nimustine; Picibanil; Vindesine | 1989 |
Serial measurement of sister chromatid exchanges in the peripheral lymphocytes of patients with lung cancer receiving chemotherapy in relation to bone marrow toxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Lymphocytes; Mitomycin; Mitomycins; Sister Chromatid Exchange; Vincristine; Vindesine | 1989 |
A phase II study of vindesine in the treatment of esophageal carcinoma. Japanese Esophageal Oncology Group.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Remission Induction; Vindesine | 1989 |
[Cisplatin combination chemotherapy in advanced lung cancer in the aged].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Etoposide; Female; Humans; Kidney; Lung Neoplasms; Male; Middle Aged; Remission Induction; Vindesine | 1989 |
[48-hour continuous infusion of vindesine (followed by cisplatin) in advanced lung cancer. Chronopharmacokinetic data and clinical efficacy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Circadian Rhythm; Cisplatin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1989 |
Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing.
Topics: Carcinoma; Cell Line; Colonic Neoplasms; Colorimetry; Coloring Agents; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Immunoglobulin G; Immunotoxins; Lung Neoplasms; Tetrazolium Salts; Thiazoles; Tritium; Tumor Cells, Cultured; Uridine; Uterine Cervical Neoplasms; Vindesine | 1989 |
Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implications.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Vindesine | 1989 |
Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Skin Neoplasms; Vindesine | 1989 |
[A case of breast cancer with multiple metastases to the lung and bone responding well to cisplatin and vindesine].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cisplatin; Female; Humans; Lung Neoplasms; Middle Aged; Remission Induction; Vindesine | 1989 |
[Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vindesine | 1988 |
The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Mitomycin; Mitomycins; Radiography; Vinblastine; Vindesine | 1988 |
Summary of recent clinical experience in whole-body hyperthermia combined with chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Evaluation Studies as Topic; Female; Humans; Hyperthermia, Induced; Lung Neoplasms; Male; Melanoma; Vincristine; Vindesine | 1988 |
Cyclophosphamide, vindesine and oral VP-16 in the treatment of non-small cell lung cancer (NSCLC): an outpatient regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Etoposide; Humans; Lung Neoplasms; Vindesine | 1988 |
[Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vindesine | 1988 |
Should chemotherapy response be evaluated separately in sequential chemotherapy-radiotherapy schedules in locally advanced nonsmall-cell lung carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Time Factors; Vindesine | 1988 |
[A case of retrocecal appendicitis occurrence during effective chemotherapy in lung cancer].
Topics: Abscess; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Appendicitis; Bone Marrow; Cecum; Cisplatin; Depression, Chemical; Humans; Ifosfamide; Intestinal Perforation; Leukopenia; Lung Neoplasms; Male; Middle Aged; Remission Induction; Rupture, Spontaneous; Vindesine | 1989 |
[Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1985 |
[Antineoplastic chemotherapy for bronchial carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Procarbazine; Vinblastine; Vincristine; Vindesine | 1985 |
Phase II study of vindesine in patients with non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Time Factors; Vindesine | 1985 |
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Vindesine | 1985 |
[Nontumoral nervous complications of bronchial cancer].
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Alcoholism; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cerebrovascular Disorders; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Nervous System Diseases; Paralysis; Paraneoplastic Syndromes; Peripheral Nervous System Diseases; Polyneuropathies; Vindesine | 1985 |
Drug sensitivity of non small cell carcinoma of lung by clonogenic assay in several media.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Survival; Cells, Cultured; Cisplatin; Colony-Forming Units Assay; Culture Media; Humans; Lung Neoplasms; Tumor Stem Cell Assay; Vindesine | 1986 |
Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Vindesine | 1986 |
Efficacy and tolerability of vindesine in the treatment of small-cell lung cancer. A phase II study.
Topics: Carcinoma, Small Cell; Drug Evaluation; Humans; Lung Neoplasms; Vindesine | 1986 |
[Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administration Schedule; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Vindesine | 1986 |
[Chemotherapy of non-small cell bronchial cancer with mitomycin C, vindesine and cisplatin. Results of a phase II study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Vindesine | 1987 |
In vitro chemosensitivity of human lung cancer for vindesine.
Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Tumor Stem Cell Assay; Vindesine | 1987 |
[A phase II study of vindesine for pretreated non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1987 |
Antitumor effect of two-drug simultaneous or sequential use of cisplatin, vindesine or etoposide on human pulmonary adenocarcinoma cell lines in tumor clonogenic assay.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cisplatin; Colony-Forming Units Assay; Etoposide; Humans; Lung Neoplasms; Tumor Stem Cell Assay; Vindesine | 1986 |
[Antiemetic treatment with metoclopramide and high-dose lorazepam and additional long-term treatment with lorazepam during CDDP administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lorazepam; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Mitomycin; Mitomycins; Vindesine; Vomiting, Anticipatory | 1988 |
[Studies on cell cycle analysis using a monoclonal antibody to bromodeoxyuridine (BrdU labeling method)].
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; Cell Line; Cisplatin; DNA, Neoplasm; Humans; In Vitro Techniques; Lung Neoplasms; Vindesine | 1988 |
[Remarkable effect of vindesine sulfate (VDS) in the treatment of metachronous lung metastasis of esophageal cancer--a case report].
Topics: Carcinoma, Squamous Cell; Drug Administration Schedule; Esophageal Neoplasms; Esophagus; Humans; Lung Neoplasms; Male; Middle Aged; Postoperative Period; Remission Induction; Vindesine | 1988 |
[A complete response in squamous cell carcinoma of the lung to combination chemotherapy by cisplatin and vindesine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Humans; Lung Neoplasms; Male; Vindesine | 1987 |
[A chemotherapy regimen including CDDP in patients with bronchogenic carcinoma--a comparison between bronchial artery infusion and intravenous administration].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Bronchogenic; Cisplatin; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Vindesine | 1986 |
Efficacy and specificity of vindesine monoclonal anti-carcinoembryonic antigen conjugate with nine human cancer cell lines.
Topics: Antibodies, Monoclonal; Antibody Specificity; Carcinoembryonic Antigen; Cell Line; Colonic Neoplasms; Enzyme-Linked Immunosorbent Assay; Evaluation Studies as Topic; Fluorescent Antibody Technique; Humans; Lung Neoplasms; Neoplasms; Rectal Neoplasms; Uridine; Vindesine | 1987 |
A case of adenocarcinoma of the lung which was successfully treated by chemotherapy with patient survival without recurrence for more than three years.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Podophyllotoxin; Smoking; Vincristine; Vindesine | 1987 |
[Early results of the treatment of non-small cell lung cancer using the PV3 protocol (cisplatin, vindesine and cobalt therapy)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cobalt Radioisotopes; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1987 |
Interstitial lung disease associated with vindesine and radiation therapy for carcinoma of the lung.
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Prednisone; Pulmonary Fibrosis; Radiation Injuries; Vindesine | 1986 |
Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Belgium; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Staging; Pilot Projects; Vindesine | 1986 |
Is there standard chemotherapy for non-small cell lung cancer?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Lung Neoplasms; Vindesine | 1986 |
[A case of asthma attack induced by high-dose metoclopramide].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asthma; Carcinoma, Bronchogenic; Cisplatin; Female; Humans; Lung Neoplasms; Metoclopramide; Vindesine | 1986 |
Vindesine and mitomycin C in inoperable non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Lung Neoplasms; Mitomycins; Vindesine | 1986 |
Enhancement of cytotoxicity of vindesine and cis-platinum for human lung tumours by the use of verapamil in vitro.
Topics: Carcinoma, Squamous Cell; Cisplatin; Drug Resistance; Drug Synergism; Humans; In Vitro Techniques; Lung Neoplasms; Verapamil; Vindesine | 1986 |
Twice weekly vindesine, a phase II study in lung cancer.
Topics: Drug Administration Schedule; Humans; Kidney Diseases; Lung Neoplasms; Vindesine | 1987 |
Efficacy and selectivity of vindesine monoclonal anti-carcinoembryonic antigen antibody conjugates on human tumor cell lines grown as xenografts in nude mice.
Topics: Animals; Antibodies, Monoclonal; Carcinoembryonic Antigen; Cell Line; Humans; Lung Neoplasms; Mice; Neoplasm Transplantation; Neoplasms; Vindesine | 1987 |
[Diagnosis and treatment of metastatic lung tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Humans; Lung Neoplasms; Picibanil; Pneumonectomy; Prognosis; Radiotherapy Dosage; Tomography, X-Ray Computed; Vindesine | 1987 |
Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Humans; Lung Diseases, Obstructive; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Vinblastine; Vindesine | 1985 |
Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytotoxicity Tests, Immunologic; Doxorubicin; Etoposide; Female; Humans; Immune Tolerance; In Vitro Techniques; Killer Cells, Natural; Lung Neoplasms; Male; Mediastinal Neoplasms; Methylprednisolone; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Vinblastine; Vindesine | 1985 |
Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1986 |
Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Vindesine | 1986 |
VP-16 and cisplatin in the treatment of non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Lung Neoplasms; Vinblastine; Vindesine | 1985 |
Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1985 |
[Inoperable lung epidermoid cancer non metastasizing. A phase II trial using radiotherapy and combined chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Follow-Up Studies; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1985 |
[Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Middle Aged; Prognosis; Vinblastine; Vindesine | 1985 |
Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1985 |
Chemotherapy of metastatic primary cardiac sarcomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Echocardiography; Heart Atria; Heart Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Male; Vinblastine; Vindesine | 1985 |
Complete remissions in non small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Lung Diseases, Obstructive; Lung Neoplasms; Retrospective Studies; Smoking; Vindesine | 1985 |
The use of human tumor clonogenic assay in predicting combination effect of cisplatin plus vindesine in carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colony-Forming Units Assay; Humans; Lung Neoplasms; Tumor Stem Cell Assay; Vindesine | 1985 |